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Abstract
Harmful substance use is a prevalent and under-treated public health problem, with use of
alcohol, tobacco, and illicit drugs among the top preventable causes of death in the United States.
The unmet need for treatment is particularly pronounced among young adults, for whom
university primary care is an important venue for early detection and intervention. Although a
number of different multi-substance use screens have been developed for primary care settings,
none have been validated in university primary care. Other behavioral health concerns are also
highly prevalent among college students, although little is known regarding how behavioral risk
factors co-occur in this setting. Accordingly, this study aimed to extend research on the validity
of the 4-item Substance Use Brief Screen (SUBS) in a university primary care setting. The
diagnostic utility of the SUBS was also compared to an established screen for at-risk drinking,
the Alcohol Use Disorder Identification Test – Consumption (AUDIT-C). Finally, this study
described prevalence rates and identified cluster profiles of multiple risk factors, including atrisk substance use, behavioral health concerns, and body mass index. Participants (n = 100) were
recruited from Syracuse University Health Services to complete self-report screens and a
structured interview. Results support the construct validity and utility of the SUBS in university
primary care, with cut-off scores of 1 for tobacco and nonmedical prescription drug use, and 2
for at-risk alcohol and illicit drug use. Results also suggest that behavioral health risk factors
commonly co-occur, thereby supporting the development of brief, combined interventions
targeting multiple risk factors in university primary care.
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Screening for At-Risk Substance Use and Behavioral Health Concerns in University Primary
Care
Harmful substance use is a prevalent and under-treated public health problem, with use of
alcohol, tobacco, and illicit drugs among the top preventable causes of death in the United States
(Mokdad, Marks, Stroup, & Gerberding, 2004). It is estimated that over 20 million individuals in
the U.S. meet criteria for Substance Use Disorder (SUD), of whom only a small percentage
receive substance use treatment (i.e., 10.8% in 2015; Lipari, Park-Lee, & Van Horn, 2016). The
unmet need for treatment is particularly pronounced among young adults aged 18-25, of whom 1
in 6 meet criteria for SUD (Lipari et al., 2016). Past-year use among young adults is especially
prevalent for alcohol (75.5%), tobacco (43.8%), cannabis (32.2%), and nonmedical use of
prescription medications (15.3%), particularly opioids and stimulants (Center for Behavioral
Health Statistics and Quality, 2016). Despite the significant health consequences of SUD (Brick,
2008), the vast majority (97%) of young adults with untreated SUD do not perceive themselves
as needing treatment (Lipari et al., 2016). Given that approximately 40% of young adults in the
United States attend college (National Center for Education Statistics, 2019), and the majority of
young adults with SUD do not seek or perceive a need for treatment, university primary care is
an important venue for early detection and intervention for at-risk substance use among college
students (Alschuler, Hoodin, & Byrd, 2008; Anderson et al., 2010).
Integrated Primary Care
The practice of integrating screening and brief intervention for behavioral health
concerns in primary care settings is known as integrated primary care (Pomerantz & Sayers,
2010; Strosahl, 1998). Screening in university primary care provides an opportunity to identify
behavioral health concerns that may otherwise go untreated, as fewer barriers exist for students
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seeking treatment for physical health in comparison to mental health or other specialty services
(Eisenberg, Golberstein, & Gollust, 2007). Integrated primary care also allows for more
collaborative, efficient, and comprehensive treatment (deGruy & Etz, 2010).
Screening and Brief Intervention in Primary Care
Although integrated primary care provides opportunities for early assessment and
intervention, it also presents unique constraints. In particular, primary care providers are
expected to assess for multiple health problems within a fifteen-minute appointment (Blumenthal
et al., 1999; Gottschalk & Flocke, 2005; Tai-Seale & McGuire, 2012). Thus, thorough
assessments of multiple behavioral health concerns are not feasible, and providers must
determine priority areas in practice. Brief screens address this constraint by identifying
potentially problematic behaviors and drawing attention to the need for further assessment or
referral. Accordingly, it is important to keep screens as brief as possible within primary care
settings so they can be completed, scored, and reviewed without taking too much time away
from the presenting problem (Funderburk, Fielder, DeMartini, & Flynn, 2012).
Although even the briefest of screens adds to the length of a primary care visit,
behavioral health screens are important in that they function as an alert and call to action for
further assessment. Screening measures also systematically call patients’ and providers’ attention
to potential behavioral health concerns that may not otherwise be addressed due to time
constraints and the decreased likelihood of addressing additional topics as time passes during the
appointment (Tai-Seale & McGuire, 2012). This is consistent with preliminary research on
patients’ and providers’ perceptions of behavioral health screens in university primary care,
which revealed that using the screens led to an increased recognition and discussion of
behavioral health concerns (Alschuler et al., 2008). Likewise, a study of students’ experiences
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with integrated behavioral health providers in University Health Services (UHS) showed that the
majority (86%) of students who remembered completing a screening measure also talked to their
provider about one or more behavioral health concerns addressed in the screen (Funderburk et
al., 2012).
There is a strong evidence base for the utility of screening and brief intervention for
reducing tobacco and alcohol use in primary care settings, and more recent research supports
screening for other substances, as well (Babor et al., 2007; Pilowsky & Wu, 2012). Changes to
insurance policies enacted with the Patient Protection and Affordable Care Act (ACA; 2010)
offer an incentive to integrate preventive screening and treatment for SUD in the context of
primary care. Likewise, a recent Surgeon General’s report recommended screening for SUD in
primary care, likening the course of SUD to other chronic illnesses routinely treated and
managed in primary care settings (U.S. Department of Health & Human Services, Office of the
Surgeon General, 2016). Given this recommendation and the context of the ACA, screening for
at-risk substance use in primary care seems increasingly relevant and feasible. Accordingly, there
is a need for substance use screening instruments that are designed and validated for use in
primary care settings.
Multi-Substance Use Screens in Primary Care
In recent years, a number of different multi-substance use screens have been developed
for primary care settings (e.g., Ali, Meena, Eastwood, Richards, & Marsden, 2013; Lanier & Ko,
2008; McNeely, Cleland, et al., 2015; McNeely, Strauss, et al., 2015; McNeely et al., 2016;
McPherson & Hersch, 2000; Tiet et al., 2015; Tiet, Leyva, Moos, & Smith, 2017, 2016). Some
of these screens have limited utility for routine use in busy primary care settings because they are
too lengthy (Ali et al., 2013; Kirisci, Reynolds, Carver, & Tarter, 2013; McNeely et al., 2016),
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too narrow in focus such that they only screen for illicit drugs but not alcohol or nonmedical
prescription drug use (Tiet et al., 2015, 2017, 2016), or validated to detect risk for SUD but not
lower levels of at-risk substance use (Kirisci et al., 2013; McNeely & Saitz, 2015; Tiet et al.,
2015). Importantly, none of these recently developed screens have been validated in university
primary care.
The Substance Use Brief Screen. The Substance Use Brief Screen (SUBS; McNeely,
Strauss, et al., 2015) is particularly promising because it is brief (i.e., 4 items), self-administered,
and developed to detect “unhealthy” alcohol, tobacco, illicit drug, and nonmedical prescription
drug use during the past 12 months (see Appendix A). Unhealthy use is defined as meeting
criteria for at-risk use according to a combination of reference standards, including moderate- or
high-risk use on the Alcohol Smoking and Substance Involvement Screening Test (ASSIST; Ali
et al., 2002; Humeniuk & World Health Organization, 2010) and the Timeline Followback
(Sobell, Maisto, Sobell, & Cooper, 1979; Sobell & Sobell, 1992). Response options are “never,”
“one to two days,” or “three or more days” in the past 12 months. For each item, endorsing any
response except “never” counts as a positive screen for that specific substance. The tobacco,
illicit drug, and nonmedical prescription drug use items assess frequency of any use. The alcohol
item is designed to measure frequency of consuming four or more standard drinks in one day.
Thus, having four or more drinks in a day, or using any tobacco, illicit drugs, or nonmedical
prescriptions drugs during the past year would result in a positive screen.
The SUBS was initially validated among adults presenting to primary care in two large
hospitals in New York City and Boston (McNeely, Strauss, et al., 2015). Subsequent research
among hospitalized adults (Han, Sherman, Link, Wang, & McNeely, 2017) showed that the
SUBS is a valid alternative to the AUDIT-C (Bradley et al., 2007; Bush, Kivlahan, McDonell,
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Fihn, & Bradley, 1998) and the ASSIST (Ali et al., 2002; Humeniuk & World Health
Organization, 2010). This is promising, as the 3-item AUDIT-C is limited by its exclusive focus
on alcohol, and the interviewer-administered ASSIST is too involved and lengthy to fit into
clinical workflows (Ali et al., 2013). Specifically, the ASSIST requires the provider to conduct
an interview lasting up to 15 minutes, as well as provide feedback and/or referrals depending on
the patient’s level of use. Despite the benefits of the brevity of the SUBS, and although the
sensitivity for the SUBS detecting at-risk drinking was high among hospitalized adults (.98), its
specificity was relatively low (.61; Han et al., 2017). A specificity (a.k.a. true negative rate) of
.61 means that only 61% of individuals who do not meet the criterion of interest (i.e., at-risk
drinking) are identified correctly as such. Therefore, the remaining 39% of individuals who
would not meet the at-risk drinking criterion upon further assessment would be incorrectly
flagged as positive by the initial screen. As a consequence of this elevated false positive rate,
screening with one at-risk drinking item on the SUBS may place unnecessary burden on health
care providers (Han et al., 2017).
It should be noted that the SUBS has not been validated in university primary care, and
accordingly the sensitivity and specificity of the SUBS is unknown in that setting. In fact, few
screens have been validated for detecting at-risk substance use in university primary care. One
exception is the AUDIT-C (Campbell & Maisto, 2018). Relative to the SUBS (in hospitalized
adults), the AUDIT-C is somewhat less sensitive and more specific in detecting at-risk drinking
in students presenting to university primary care. Specifically, the AUDIT-C demonstrated
sensitivity of .90 for females (.95 for males) and specificity of .77 for females (.81 for males;
(Campbell & Maisto, 2018). Greater specificity indicates that a screen has fewer false positives,
which is desirable in primary care settings where time and resources are limited. Considering the
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need for providers to judiciously allocate their limited time with each patient (Tai-Seale &
McGuire, 2012), further research is needed comparing the SUBS to other established screens for
at-risk drinking (i.e., the AUDIT-C), with an eye toward maximizing specificity and thereby
minimizing false positives.
Despite the benefits of its potentially greater specificity, the AUDIT-C may have less
clinical utility than the SUBS because the AUDIT-C does not detect other problematic substance
use, also prevalent among college students (Johnston, O’Malley, Bachman, Schulenberg, &
Miech, 2016). When deciding on which screen(s) to implement, primary care providers should
consider both sensitivity and specificity, as well as the clinical utility of the screening instrument.
For instance, if sensitivity and specificity are comparable, a 4-item screen for four separate
substances (e.g., SUBS) would be more clinically informative than a 3-item screen for one
substance (e.g., AUDIT-C).
One additional limitation of the SUBS is that it does not directly screen for concurrent
use of multiple substances. This is important, particularly for college students, because research
suggests that young adults experience elevated negative consequences when substances are used
concurrently (e.g., simultaneous alcohol and marijuana use; (Agosti, Nunes, & Levin, 2002). The
co-occurrence of marijuana and alcohol during adolescence and young adulthood in particular is
uniquely associated with impairments in subsequent brain development (Jacobus, Squeglia,
Meruelo, et al., 2015), cognitive functioning (Jacobus, Squeglia, Infante, et al., 2015), and
academic performance (Meda et al., 2017). This limitation could be remedied by adding one
additional item to the SUBS assessing concurrent use of multiple substances.
Additional Behavioral Health Screening
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In addition to substance use, other behavioral health concerns are highly prevalent among
college students. A recent national survey shows that 15% to 30% of college students endorse
elevated anxiety, depression, sleep difficulties, and/or stress that impairs their academic
performance (American College Health Association, 2016). Data from the American College
Health Association national survey suggests that these behavioral health problems commonly cooccur, such that 10.9% of students endorse both depression and anxiety during the past year, and
7.7% endorse a combination of two or more other behavioral health concerns.
One study on behavioral health screening at Syracuse UHS provides information
regarding the prevalence of positive screens in the context of university primary care
(Shepardson & Funderburk, 2014). During the Spring 2010 semester, 38.3% of students screened
positive for at-risk alcohol use, 13.3% endorsed sleep problems, 9.5% endorsed wanting to talk
to someone about smoking cessation, 9.1% screened positive for depression, and 2.5% endorsed
suicidal ideation (Shepardson & Funderburk, 2014). Other behavioral health concerns were not
assessed (e.g., anxiety, trauma, abuse of prescription medications, cannabis, or other drugs).
Although these prevalence data are helpful for describing risk factors for students presenting to
university primary care, little is known regarding how these risk factors co-occur in this setting.
Likewise, the American College Health Association national survey (2016) does not report
prevalence data regarding how specific problems co-occur, with the exception of depression and
anxiety.
Accordingly, research is needed regarding the co-occurrence of positive screens in
university primary care. Prevalence data on the co-occurrence of positive screens has the
potential to inform the development of integrated treatments in university primary care settings,
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which may ultimately improve the efficiency and cost effectiveness of behavioral health
interventions (J. J. Prochaska, Spring, & Nigg, 2008; J. O. Prochaska, 2008).
Much of the research on co-occurring risk factors has focused on the four leading
contributors to preventable disease and mortality in the United States: at-risk drinking, tobacco
use, physical inactivity, and unhealthy diet (Babor, Sciamanna, & Pronk, 2004). These risk
factors tend to co-occur, such that a slight majority (52%) of U.S. adults in primary care report
two or more (Coups, Gaba, & Orleans, 2004). There is also evidence that certain risk factors tend
to co-occur according to identifiable patterns, or clusters, and that these clusters can predict
future healthcare utilization (Funderburk, Maisto, & Labbe, 2014; Funderburk, Maisto,
Sugarman, & Wade, 2008). Few studies have examined how these risk factors cluster together in
college student samples in the United States (e.g., Kang et al., 2014; Quintiliani, Allen, Marino,
Kelly-Weeder, & Li, 2010), none of which have examined co-occurrence as indicated by positive
screens in primary care settings.
Study Aims
This review has shown that the Substance Use Brief Screen (SUBS) does not have
empirically demonstrated utility among college students presenting to university primary care. In
fact, no multi-substance use screen has been validated in university primary care. Furthermore, it
would be informative to compare the diagnostic utility of the SUBS to previously validated
screens in the university primary care setting. Finally, no prior research in the United States has
described the co-occurrence and clustering of behavioral risk factors among students utilizing
university primary care.
The primary aim of this study was to replicate and extend research on the validity of the
SUBS (McNeely, Strauss, et al., 2015) when used in a university primary care setting. Bivariate
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correlations and Receiver Operating Characteristic (ROC) curve analyses tested the construct
validity and utility of the SUBS for detecting at-risk drinking, and at-risk use of tobacco, illicit
drugs, nonmedical prescription drugs, and concurrent multiple substance use (Metz, 1978). It
was hypothesized that the SUBS item for each class of substance would be positively correlated
with its respective score on the ASSIST. It was also expected that the SUBS would perform
significantly better than chance in detecting at-risk substance use, as indicated by ROC curve
analyses. Regarding optimal cut-off scores, prior research indicates that higher cut-off scores are
recommended for college students relative to community samples of adults (Campbell & Maisto,
2018; DeMartini & Carey, 2012; Kelly, Donovan, Chung, Bukstein, & Cornelius, 2009). Lower
levels of substance use, as indicated by the cut-off of 1 on the SUBS, may be less risky among
college students for a number of reasons, including fewer responsibilities and obligations (e.g.,
family, employment) and protective factors that make the college environment safer relative to
substance use outside the confines of college life (Colby, Colby, & Raymond, 2009). Research
on drinking norms also suggests that heavy drinking is perceived as less harmful among young
adult college students relative to older, employed adults (Colby, Swanton, & Colby, 2012) and
that college students who moderate their drinking may in fact experience negative social
consequences (Robertson & Tustin, 2018). Accordingly, it was hypothesized that at-risk
substance use, as indicated by the ASSIST, would be best predicted by a cut-off score of 2 on the
SUBS.
A secondary aim of this study was to compare the utility of the SUBS alcohol item to the
AUDIT-C in detecting at-risk drinking. Diagnostic indices of the SUBS alcohol item were
compared to those of the AUDIT-C. The practical benefit of a 1-item alcohol screen (SUBS) in
comparison to a 3-item screen (AUDIT-C) was also considered to inform clinical practice.
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A third, exploratory aim was to describe prevalence rates and identify cluster profiles of
multiple risk factors in university primary care. Brief screens were used to identify the following
risk factors: substance use (at-risk alcohol, tobacco, illicit drug, and nonmedical prescription
drug use), mental health problems (anxiety, depression, sleep difficulties, posttraumatic stress,
and suicidal ideation), and a proxy for other lifestyle factors (BMI). Cluster analyses were
conducted to describe whether and how these risk factors cluster together.
Methods
Study Procedures
Data collection began in February 2018 and concluded in June 2018. All students age 18
or older presenting for any type of medical care at UHS were eligible to participate. Patients
were recruited from the UHS waiting room by research assistants seated at a table near the
entrance. Information sheets describing the study were also placed at check-in stations and
throughout the waiting room. Research assistants introduced the study by offering patients the
option to participate in a research study about students’ health behaviors, including substance
use, and emphasizing that the information would be for research purposes only and would not be
discussed with providers or anyone else outside the research team. Patients were given the option
to sign up for a research session at a specified time or to provide their email address so that they
could be sent a link to schedule a research session at another time that was convenient to them.
This contact information was used solely for recruitment and was not tied in any way to
participant data. Patients were encouraged to schedule for same-day research sessions, when
available.
Upon presenting to their research session, participants completed informed consent,
followed by the ASSIST interview, had their height/weight measured, and completed a battery of
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screening measures. Study procedures, excluding informed consent, lasted an average of 22
minutes per participant (m = 21.91, SD = 6.24).
Compensation. For purposes of compensation, participants were invited to provide an
email address after they completed the study procedures. Email addresses were added to a
database kept separate from any participant data. Email addresses were solely used for
compensation and were not linked to any participant data or other identifying information.
The first 21 participants were entered into a prize drawing for one of ten $100 gift cards.
After five weeks of data collection, additional compensation was added to improve recruitment
rates. The remaining 79 participants were each compensated with a $10 e-gift card and were also
entered into the prize drawing so that the odds of winning were consistent across all participants.
The prize drawing occurred upon the study’s completion.
Debriefing and referrals. After completing all study procedures, participants were
debriefed and offered referral information for on-campus and community resources. Students
who screened positive for suicidal ideation were offered a suicide risk assessment completed by
a graduate student clinician under the supervision of a licensed clinical psychologist. Protocols
were in place so that students endorsing current suicidal ideation with intent or plan would
immediately be connected to the Syracuse University Counseling Center for crisis services. No
participants required an immediate referral for crisis services.
Participants. A sample of 100 students was recruited for the study. See Table 1 for
demographic information. The sample was predominantly female (76.8%). The average age was
23.3 years, and 43% were graduate students. Most (70%) were not involved in Greek life, and
67% spoke English as their first language. Identified race was 43% White, 34% Asian, 10%
Multi-racial, 8% Black, and 5% Other. Twelve percent of participants identified as Hispanic.
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To provide context for the setting in which the study occurred, the university student
population is approximately 55% female, 75% white, with a mean age of 21 years old (Syracuse
University, 2016). As of 2016, the university consisted of 25% graduate students, and the
remaining 75% of undergraduates were a relatively even distribution of freshmen, sophomores,
juniors, and seniors.
To further examine representativeness of data, unpublished and de-identified data were
obtained from UHS regarding demographics of patients seen at UHS during the Fall 2017
semester; data were not available for the Spring 2018 semester. Compared to the demographics
of students seen at UHS, the current study sample included a greater proportion of students
identifying as female (77% vs. 61%), Asian (34% vs. 25%) and graduate students (43% vs.
22%). The study sample was also somewhat older (m = 23.32, SD = 5.56) on average, than the
typical student seen at UHS (m = 21.43, SD = 4.06). Although the UHS data from Fall 2017 did
not include information on ESL status, it is known that 28% of those patients were international
students from outside the United States. This approximates the 33% of students in the current
study who identified English as a second language.
Measures (See Appendices)
Substance Use Brief Screen. The Substance Use Brief Screen (SUBS; McNeely,
Strauss, et al., 2015) is a 4-item, self-administered screen developed to detect past-year at-risk
alcohol, tobacco, illicit drug, and nonmedical prescription drug use. Response options are
“never,” “one to two days,” or “three or more days” in the past 12 months. For each item,
endorsing any response except “never” counts as a positive screen for that specific substance.
The tobacco, illicit drug, and nonmedical prescription drug use items assess frequency of any
use. The alcohol item is designed to measure frequency of consuming 4 or more standard drinks
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in one day. Initial research suggests the SUBS has good test-retest reliability, construct validity,
and feasibility in primary care settings (McNeely, Strauss, et al., 2015). For the present study, an
additional item was added to the SUBS to screen for concurrent use of multiple substances (see
Appendix B).
Substance use reference standard. The Alcohol, Smoking and Substance Involvement
Screening Test (ASSIST; Ali et al., 2002; Humeniuk & World Health Organization, 2010) is a
structured interview that served as a reference standard for determining whether participants met
criteria for at-risk substance use (i.e., at-risk use of alcohol, tobacco, illicit drugs, and
nonmedical prescription drugs). At-risk use was defined by a score of 11 or more for alcohol and
a score of 4 or more for all other substances (Humeniuk & World Health Organization, 2010).
The ASSIST consists of eight questions, the first of which queries for lifetime substance use,
followed by six questions about substance-related problems for each endorsed substance (i.e.,
questions 2 through 7), and a final question about injection drug use. Questions 2 through 7 are
summed to create an ASSIST score for each class of substance, also referred to as the substance
involvement score (Humeniuk, Ali, & WHO ASSIST Phase II Study Group, 2006; Humeniuk &
World Health Organization, 2010). Item 5, which indicates failure to do what is normally
expected of you, is excluded from the tobacco ASSIST score (Humeniuk & World Health
Organization, 2010). Among adults in primary care and specialty treatment settings, the ASSIST
has demonstrated strong test-retest reliability and internal consistency, as well as strong
concurrent, predictive, discriminative, and construct validity (Humeniuk et al., 2006; McNeely et
al., 2014; WHO ASSIST Working Group, 2002). Consistent with prior research screening for
nonmedical use of prescription drugs, two classes of substances were added to the ASSIST:
prescription opioids and prescription stimulants (Han et al., 2017; McNeely et al., 2014, 2016).
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This addition is also consistent with the NIDA-modified ASSIST (National Institute on Drug
Abuse, 2009). For purposes of differentiating between prescription and non-prescription drugs,
the current study also added a class of substances for prescription sedatives. Lastly, in order to
correspond with the time frame referenced on the SUBS, the current study modified the ASSIST
time frame to refer to the past twelve months rather than the past three months. Cronbach’s alpha
for each substance involvement score was generally acceptable (above .70) in the current sample.
Alcohol use screen. The Alcohol Use Disorders Identification Test-Consumption
(AUDIT-C; Bradley et al., 2007; Bush et al., 1998) is a 3-item screen for at-risk drinking derived
from the first three items on the AUDIT (Babor, Higgins-Biddle, Saunders, & Monteiro, 2001;
Saunders, Aasland, Babor, de la Fuente, & Grant, 1993). The AUDIT-C items are each rated on a
scale from 0 to 4 and address drinking frequency, typical quantity, and frequency of heavy
drinking (i.e., “five or more drinks on one occasion”) over the past year. Instructions include the
definition of a “standard drink” (i.e., a 12 oz. beer, 5 oz. glass of wine, or 1.5 oz. shot of liquor;
National Institute on Alcohol Abuse and Alcoholism, 2005). The AUDIT-C has demonstrated
strong construct validity across settings, including primary care (Bradley et al., 2007; Campbell
& Maisto, 2018; Kriston, Hölzel, Weiser, Berner, & Härter, 2008). Prior research in university
primary care suggests optimal cut-off scores of 5 for females and 7 for males to detect at-risk
drinking (Campbell & Maisto, 2018). In the current sample, internal consistency of the AUDITC was acceptable, with Cronbach’s alpha equal to 0.80.
Behavioral health screens. Additional behavioral health concerns that are particularly
prevalent among college students (i.e., anxiety, depression, sleep difficulties, and posttraumatic
stress) were screened for using measures designed to be implemented in primary care settings.
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Elevated risk for depression, sleep disturbance, and suicidal ideation were screened for
using the 9-item Patient Health Questionnaire (PHQ-9), a validated measure of depression
severity developed for use in primary care (Kroenke, Spitzer, & Williams, 2001). Scores of 10 or
higher indicate positive screens for moderate depression (Kroenke et al., 2001). In the current
sample, Cronbach’s alpha was 0.84 for the PHQ-9, indicating acceptable internal consistency.
Based on prior research (MacGregor, Funderburk, Pigeon, & Maisto, 2012; Shepardson
& Funderburk, 2014), individual items from the PHQ-9 were examined as screeners for sleep
disturbance (item 3) and suicidal ideation (item 9). Research suggests that the PHQ-9 item 3
screen for sleep disturbance is a valid alternative to longer sleep questionnaires, with any score
above 0 indicating a positive screen (MacGregor et al., 2012). The one item screen for suicidal
ideation is currently used in clinical practice at Syracuse UHS (Shepardson & Funderburk, 2014)
and is comparable to longer self-report screens (Uebelacker, German, Gaudiano, & Miller,
2011). Any score above 0 on item 9 was considered a positive screen indicating a need to further
assess for suicidal ideation (Uebelacker et al., 2011).
The Generalized Anxiety Disorder 7-item scale (GAD-7) was developed in primary care
settings and was used as a screen for increased risk of anxiety disorders (Kroenke, Spitzer,
Williams, Monahan, & Löwe, 2007; Spitzer, Kroenke, Williams, & Löwe, 2006). A score of 10
or higher suggests moderate risk for an anxiety disorder and need for further assessment. The
GAD-7 has demonstrated good internal consistency and construct validity across settings,
including primary care (Jordan, Shedden-Mora, & Löwe, 2017; Löwe et al., 2008; Zhong et al.,
2015). In the current sample, internal consistency was acceptable (Cronbach’s alpha = 0.86).
Elevated risk for posttraumatic stress disorder (PTSD) was screened for via the 4-item
Primary Care PTSD screen (PC-PTSD; Prins et al., 2004). The PC-PTSD has been used
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extensively in Department of Veterans Affairs primary care settings to screen for the presence of
posttraumatic stress symptoms (i.e., re-experiencing, hyper-arousal, avoidance, and numbing),
with a cut-off score of 3 indicating increased risk for PTSD with a sensitivity of .78 and
specificity of .87 (Prins et al., 2004). The PC-PTSD has demonstrated sound psychometric
properties among recent combat veterans as well as veterans seen in primary care (Bliese et al.,
2008; Ouimette, Wade, Prins, & Schohn, 2008). Specifically, the PC-PTSD demonstrated
diagnostic efficiency equivalent to the 17-item PTSD Checklist (Weathers, Litz, Herman, Huska,
& Keane, 1993), as well as strong predictive validity for the criterion of a PTSD diagnosis as
determined by a clinical interview (Bliese et al., 2008; Ouimette et al., 2008). In the current
sample, internal consistency was acceptable (Cronbach’s alpha = 0.73). In a prior study that
recruited students who had utilized Syracuse UHS, 20.3% screened positive (with a score of 3 or
4) on the PC-PTSD (Johnson, Brenner, Campbell, & Maisto, 2018). The PC-PTSD-5, a recent
update to the PC-PTSD, was not used in the current study because it has yet to be validated
beyond its original study and has no precedent for use among college student samples (Prins et
al., 2016).
Body mass index. Although unhealthy diet is a leading contributor to preventable disease
and mortality in the United States (Babor et al., 2004), there is no consensus regarding how best
to operationalize dietary intake (Jones, 2002; Plotnikoff et al., 2015; Shao et al., 2017). In fact,
the healthiest diets are characterized by numerous factors that are more complicated than can be
summarized in a brief screen (Willcox, Willcox, Todoriki, & Suzuki, 2009). However, body
mass index (BMI) is a commonly used metric in primary care (Lopez-Jimenez & Miranda, 2010)
and can be used as a proxy measure for dietary intake (Bailey & Ferro-Luzzi, 1995). BMI was
calculated according to height and weight using the formula: weight [lbs]/ height [inches]2 *703
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(National Heart, Lung, and Blood Institute, 1998). Height and weight were directly measured
during the research session. Unhealthy BMI was indicated by a score below 18.5, indicating
underweight, or 25.0 or higher, indicating overweight or obesity.
Demographics. A demographics questionnaire asked participants to report age, gender,
year in school, GPA, race, ethnicity, and Greek like involvement (i.e., fraternity/sorority
membership). Given that approximately 20% of students enrolled at SU are international
students (Syracuse University, n.d.), participants were also asked to indicate whether they speak
English as a second language (ESL) or English as their first language (non-ESL).
Data Analyses
Data cleaning. Prior to analyses, data distributions were examined for outliers and
checked for missing data. Variables with skewed or kurtotic distributions were not transformed
because analyses did not assume normality.
Validity and utility of the SUBS. Concurrent validity of the SUBS was examined
through bivariate nonparametric correlations between the SUBS and the ASSIST. Specifically,
correlations were examined between the SUBS tobacco score and ASSIST tobacco score, the
SUBS alcohol score and ASSIST alcohol score, the SUBS illicit drug score and the sum of all
ASSIST illicit drug scores (i.e., cannabis, cocaine, methamphetamine, inhalants, street sedatives,
hallucinogens, and street opioids), and the SUBs nonmedical prescription drug score and the sum
of all ASSIST nonmedical prescription drug scores (i.e., prescriptions stimulants, sedatives, and
opioids). Concurrent validity of the SUBS alcohol use item was also examined through bivariate
nonparametric correlations with the AUDIT-C.
Receiver Operating Characteristic (ROC) curve analyses (Metz, 1978) tested the utility of
the SUBS for detecting at-risk use of alcohol, tobacco, illicit drugs, and nonmedical prescription
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drugs. ROC curves plotted the false positive fraction (1 - specificity) against the true positive
fraction (sensitivity) at each score on the SUBS. The area under the ROC curve (AUC) suggests
how well the screen differentiates between those who are positive versus those who are negative
for the criterion of interest (i.e., at-risk use on the ASSIST).
Reference standards were ASSIST at-risk use, as defined by a score of 11 or more for
alcohol and a score of 4 or more for all other substances (Humeniuk & World Health
Organization, 2010). The tobacco and alcohol criteria were based on their respective ASSIST
scores (Humeniuk et al., 2006). For nonmedical prescription drug use and illicit drug use,
participants were categorized as at-risk if they met the at-risk criterion for any substance within
that category. Specifically, the nonmedical prescription drug criterion was based on at-risk use as
indicated by ASSIST scores for prescription stimulants, prescription sedatives, or prescription
opioids. The illicit drug criterion was based on at-risk use as indicated by ASSIST scores for
cannabis, cocaine, methamphetamine, inhalants, street sedatives (e.g., Rohypnol), hallucinogens,
or street opioids (e.g., heroin). ROC curve analyses were not conducted for concurrent use of
multiple substances, as there was no measure in the current study that could be used as a
reference standard for that criterion.
For any criterion of interest, a cut-off score is defined as the value for which screening at
or above that score indicates a reasonable likelihood of meeting that criterion. For the SUBS, an
empirically derived cut-off score functions as an indicator of the point at which an individual
likely meets the criteria of at-risk substance use, thereby warranting further assessment. Optimal
cut-off scores were identified based on the SUBS score that maximized combined sensitivity and
specificity, as indicated by Youden’s Index (J), where
J = sensitivity + specificity -1; (Youden, 1950).
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Youden’s Index indicates the diagnostic ability of each possible cut-off score by equally
weighing specificity and sensitivity. A cut-off score with no diagnostic ability would have a J
equal to zero, whereas a diagnostically perfect cut-off score would have a J equal to one. In cases
where sensitivity and specificity cannot both be maximized, sensitivity is prioritized. This is
because in primary care settings, the risk of failing to detect a potential problem likely outweighs
the risk associated with providers unnecessarily conducting further assessment and associated
costs of untreated substance use problems (Bush et al., 1998).
ROC analyses were also conducted with the sample separated by gender. Specifically,
ROC curves were plotted for each gender to determine their corresponding diagnostic indices
(e.g., AUC, sensitivity, specificity) and to determine whether optimal SUBS cut-off scores
differed according to gender in the current sample. This is based on prior research suggesting
that higher cut-off scores be used for men than for women on substance use screens (Campbell &
Maisto, 2018; DeMartini & Carey, 2012; Neumann et al., 2004).
Comparing SUBS to AUDIT-C. To compare the utility of the SUBS alcohol item to the
AUDIT-C in detecting at-risk drinking, diagnostic indices of the SUBS alcohol item were
compared to diagnostic indices of the AUDIT-C (e.g., AUC, specificity, sensitivity). In addition
to a visual inspection of diagnostic indices, ROC curves were plotted for both screens to
determine their corresponding AUC values. The difference between the two AUC values was
compared according to a nonparametric test for dependent ROC curves (DeLong, DeLong, &
Clarke-Pearson, 1988) using the pROC package (Robin et al., 2011) in R version 3.5.3.
Cluster analyses of multiple risk factors. Descriptive statistics were provided to
illustrate the frequency of positive screening rates and co-occurrence of the risk factors identified
earlier: substance use (at-risk alcohol, tobacco, illicit drug, and nonmedical prescription drug
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use), mental health problems (anxiety, depression, sleep difficulties, posttraumatic stress, and
suicidal ideation), and BMI. Descriptive statistics include positive screening rates for each risk
factor, as well as the most common combinations of risk factors (see Funderburk, Maisto, &
Sugarman, 2007). Cluster analyses determined whether and how these risk factors cluster
together. Cluster analyses function to identify profiles of behaviors (i.e., risk factors) that tend to
cluster together (McAloney, Graham, Law, & Platt, 2013). More specifically, the Two-Step
Cluster Analysis procedure in SPSS standardizes and “pre-clusters” the data and then applies a
hierarchical clustering algorithm to identify groups of participants with similar risk factor
profiles (Norušis, 2012; Yim & Ramdeen, 2015).
Within the Two-Step procedure, hierarchical clustering was used to determine the
number of groups that best represent the underlying structure of the data because the number of
groups was unknown a priori, therefore precluding use of k-means clustering (Chiu, Fang,
Chen, Wang, & Jeris, 2001; Yim & Ramdeen, 2015). The number of clusters was automatically
determined by the Two-Step procedure, which is based on an estimate using the Bayes
Information Criterion (BIC) that is then refined to determine the optimal number of clusters
(Chiu et al., 2001). Individual records were each assigned to their closest cluster according to a
log-likelihood distance measure (SPSS, 2001). The Two-Step procedure is preferred for these
exploratory analyses because it does not require the number of expected clusters to be
determined a priori and allows for clustering of both continuous and categorical variables (Chiu
et al., 2001; Zhang, Ramakrishnan, & Livny, 1996).
A Priori Power Analyses
The vast majority of research utilizing ROC curve analyses does not include power
analyses or a priori estimates of sample size (Bachmann, Puhan, ter Riet, & Bossuyt, 2006).
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However, formulas for estimating sample size are presented by Hanley and McNeil (1982), with
which sample size can be determined according to AUC estimates and the proportion expected to
meet the criteria of interest. For the current analyses, a primary concern was having sufficient
sample size to accurately discriminate between individuals meeting vs. not meeting the criteria of
interest, which were assessed one at a time (i.e., one criterion per ROC curve).
Previous research (McNeely, Strauss, et al., 2015) provided a basis for AUC estimates for
the SUBS in detecting at-risk use: .74 (nonmedical prescription drug use), .81 (alcohol), .89
(illicit drugs), and .97 (tobacco use). AUC estimates were comparable (ranging from .74 to .86)
for detecting elevated risk for SUD (McNeely, Strauss, et al., 2015). Because the AUC describes
the probability of the SUBS correctly classifying individuals according to whether or not they
meet the criterion of interest (i.e., at-risk substance use), the null hypothesis was that the SUBS
would perform no better than chance, as indicated by an AUC = .50. Accordingly, a sample size
of 100 was expected to allow for adequate power to detect the difference between the lowest
anticipated AUC (.74) and chance (.50), power = .90 (PASS 15 Power Analysis and Sample Size
Software, 2017).
Results
Data Preparation
Missing data and outliers. Missing ASSIST data were replaced with 0 for three cases in
which items had been skipped but other responses indicated the response was likely “no”
(represented by a 0). To determine whether replacing this data with 0’s might have biased
results, analyses were run both with and without the replaced 0’s. Results did not differ, and
accordingly results are reported with the missing data replaced.
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Gender and GPA were missing for one participant each; these missing data were not
replaced. Six participants had missing data on the PHQ-9 and two had missing data on the PCPTSD for which the intended response could not be inferred, and therefore missing data were not
replaced and were excluded pairwise (not listwise, so that a participant’s data could be included
on analyses for which complete data were available). No participants were missing data for
suicidal ideation, anxiety, or BMI.
Five participants had missing data for one or more behavioral health screens that could
not be determined and were thus excluded from analyses. When determining at-risk status for
behavioral health variables, participants with missing data were included in two instances: 1) if
the sum of available data exceeded the threshold for at-risk status, or 2) if the sum of available
data fell far enough below the threshold that it could not exceed that threshold even if the
missing item were replaced with the maximum possible value for that item. Based on these rules,
depression at-risk status was determined for 5 out of 6 participants with missing data, 4 of which
were negative screens and 1 was positive. PTSD at-risk status could also be determined for 1 out
of 2 participants with missing data; that participant’s status was coded as negative. Two
participants with missing data (1 depression, 1 PTSD) maintained missing screening status due to
the sum of available data being below but close to the threshold, such that likely screening status
could not be determined. Three participants were missing data for sleep problems. Screening
statuses for sleep problems could not be determined for those 3 participants, namely because
they were derived from single items on the PHQ-9.
No outliers were identified in the data, potentially due to data collection procedures that
minimized error (i.e., restricting responses to a possible range).
Descriptive Data
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Substance use. Substance use variables were summarized for the whole sample (see
Tables 2 and 3). The mean AUDIT-C score was 3.67 (SD = 2.54). On the SUBS, 74% endorsed
any past-year heavy drinking, 39% endorsed past-year tobacco use, 56% endorsed past-year
illicit drug use, 19% endorsed past-year recreational use of prescription drugs, and 51% endorsed
past-year concurrent use of multiple substances. On the ASSIST, participants screened positive
for at-risk substance use at the following rates: 39% alcohol, 22% tobacco, 33% illicit drugs, and
7% nonmedical prescription drugs. As shown in Table 3, the most commonly used substances
during the past year were alcohol (91%), cannabis (54%), and tobacco (37%). Participants also
endorsed past-year use of cocaine (13%), prescription stimulants (13%), prescription sedatives
(7%), and hallucinogens (4%). Almost a third of participants (33%) endorsed past-year nicotine
use via e-cigarettes (e.g., vaping, “juul”).
Validity and Utility of the SUBS
Construct validity. As expected, bivariate nonparametric correlations between each
SUBS item and its corresponding ASSIST sum was statistically significant (p < .001). See
Tables 4 and 5 for correlation coefficients. The SUBS alcohol item was also significantly
corelated with the AUDIT-C (rs = .736, p <. 001), providing further evidence supporting its
concurrent validity.
Cut-off scores. All AUC values were significantly greater than .50 (p < .01), indicating
that each SUBS item performed better than chance at categorizing participants according to atrisk status on the ASSIST (see Table 6). Furthermore, all AUC values were greater than .70,
indicating adequate discrimination (Hanley & McNeil, 1982); however, the AUC for tobacco use
was good (greater than .80) and the AUC for illicit drug use was excellent (greater than .90). See
Tables 7-10 for ROC curve indices for each class of substance. An examination of Youden’s
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index indicates optimal cut-off scores of 2 for detecting at-risk alcohol use (see Table 7) and atrisk illicit drug use (see Table 8). At-risk tobacco and nonmedical prescription drug use were
detected at the lower optimal cut-off score of 1 (see Tables 9 and 10).
Comparing Screens for At-Risk Alcohol Use
AUDIT-C cut-off scores. ROC curves were also generated for the AUDIT-C with the atrisk alcohol use criterion on the ASSIST. The AUC value for the AUDIT-C detecting at-risk
alcohol use was significantly greater than .50 (AUC = .812, SE = .042, p < .001). Examination of
diagnostic indices suggests an optimal cut-off score of 4 on the AUDIT-C (see Table 11).
Direct comparison of ROC curves. To examine the utility of the AUDIT-C relative to
the SUBS alcohol item in detecting at-risk drinking, diagnostic indices of the SUBS alcohol item
were compared to diagnostic indices of the AUDIT-C (e.g., AUC, specificity, sensitivity). AUC
was higher for the AUDIT-C (AUC = .812, SE = .042) than for the SUBS alcohol item (AUC =
.740, SE = .05). Delong’s test for two correlated ROC curves was not significant (Z = -1.91, p =
.055) but did provide trend-level support for the AUDIT-C out-performing the SUBS in
classifying participants according to the ASSIST criterion of at-risk alcohol use.
At the optimal cut-off score of 2, the SUBS alcohol item had a sensitivity of .846 and a
specificity of .623. Relative to the SUBS, the AUDIT-C had somewhat lower sensitivity (.769)
and greater specificity (.705) at the optimal cut-off score of 4. At their respective optimal cut-off
scores, Youden’s index was comparable for the SUBS alcohol item (J = .496) and the AUDIT-C
(J = .474).
Exploratory Analyses: Demographic Differences
Gender comparisons. Given the large over-representation of students who were female
(76.8%), graduate students (43%), and spoke English as a second language (33%), the likelihood

25
of at-risk use on the ASSIST was compared according to those three variables. As demonstrated
in Table 12, chi square tests suggest that males and females did not differ in their rates of
ASSIST at-risk use of tobacco, illicit drugs, or nonmedical prescription drugs. There was,
however, a significant gender difference in rates for ASSIST at-risk alcohol use. Specifically,
females were more likely to screen positive (44.7% of females) than were males (21.7% of
males).
Graduate student status comparisons. Undergraduate students did not significantly
differ from graduate students in likelihood of a meeting criteria for ASSIST at-risk nonmedical
prescription drug use and were marginally more likely to screen positive for at-risk tobacco use
(see Table 13). Compared to graduate students, undergraduates were significantly more likely to
meet criteria for at-risk alcohol use (47.4% of undergrads vs. 27.9% of grads) and illicit drug use
(47.4% of undergrads vs. 14.0% of grads).
Language-based comparisons. As shown in Table 14, students who spoke English as a
first language (non-ESL) were more likely to meet criteria for ASSIST at-risk alcohol and illicit
drug use (p < .05) and were marginally more likely to meet criteria for nonmedical prescription
drugs (p = .054) relative to students whose first language was not English (ESL). Tobacco use
risk did not differ according to English-language status (p = .70).
ROC curve analyses with sub-samples. As identified earlier, there were significant
differences in likelihood of meeting criteria for at-risk alcohol and illicit drug use on the ASSIST
according to demographic characteristics. Accordingly, when groups differed in these ASSIST
outcomes, ROC curve analyses were conducted to determine whether SUBS and AUDIT-C cutoff scores also differed.
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SUBS alcohol item by gender, graduate student status, and language. The AUC for the
SUBS alcohol item classifying according to ASSIST at-risk alcohol use was not significant for
males (p = .351; see Table 15). Accordingly, the optimal SUBS alcohol cut-off score was not
identified for males. The AUC for the SUBS alcohol item was statistically significant for
females, undergraduates and graduate students, and students who speak English as a first
language (see Table 15). For these subgroups, Youden’s index suggested an optimal cut-off
score of 2. For ESL students, the AUC was marginally significant (AUC = .775, p = .053); only
5 students met the ASSIST at-risk alcohol use criterion and the 28 remaining ESL students did
not meet the criteria. Youden’s index suggested an optimal cut-off score of 1 for ESL students,
although this should be considered tentative given the small sample size and marginal statistical
significance of the AUC.
AUDIT-C by gender, graduate student status, and language. The AUC for the AUDITC screen classifying according to the ASSIST at-risk alcohol use was also not significant for
males (p = .157). AUC values for the remaining subgroups were statistically significant (p < .05;
see Table 15). Optimal AUDIT-C cut-off scores were: 2 for graduate students and ESL students,
4 for females, and 5 for undergraduate students and non-ESL students.
SUBS illicit drug item by graduate student status and language. The AUC values for
the ROC curve classifying SUBS illicit drug use according to the ASSIST were statistically
significant for subsamples of undergraduate students, graduate students, ESL students, and nonESL students (see Table 15). Optimal SUBS illicit drug cut-off scores were: 2 for undergraduates
and non-ESL students, and 1 for graduate students and ESL students.
Exploratory Cluster Analyses: Behavioral Health Risk Factors
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Combinations of risk factors. In order to describe the occurrence of multiple riskfactors, positive screening rates were determined using established cut-off scores (as described
earlier, in Measures). Cut-off scores for the SUBS were based on the results of the current study
(i.e., 1 for tobacco and nonmedical prescription drug use, 2 for heavy alcohol use and illicit drug
use). Table 16 provides descriptive information for each behavioral health screen; Table 17
presents the positive screening rates for each risk factor, as well as cut-off scores used to
determine the presence of a positive screen. The most common positive screens, endorsed by
over a third of participants, were sleep difficulties (65%), at-risk alcohol use (56%), unhealthy
BMI (40%), tobacco use (39%), and illicit drug use (36%). Fourteen percent of participants
screened positive for suicidal ideation on the PHQ-9. As described earlier (see Procedures),
participants who screened positive for suicidal ideation were offered a suicide risk assessment.
No participants endorsed current suicidal ideation with intent or plan, and therefore no
immediate referrals for crisis services were indicated.
Table 18 presents the number of positive screens (a.k.a., risk factors) present in this
sample. The modal number of risk factors was 2, median was 3, and mean was 3.13. Table 19
presents the combinations of risk factors that occurred more than once. The most prevalent
individual positive screens (i.e., BMI, sleep, and alcohol) also comprised the most common
combinations.
Cluster analyses. Exploratory Two-Step cluster analyses identified a four-group solution
that represents the underlying structure of the data (i.e., the ten risk factors), illustrated in Table
20. The Two-Step procedure identified depression and alcohol use as the most important
variables for differentiating the clusters [Variable Importance (VI) = .90], followed by tobacco
and illicit drugs (VI = .46), PTSD (VI = .43), recreational prescription drugs (VI = .34), BMI (VI
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= .28), anxiety (VI = .18), and lastly sleep (VI = .14). Table 21 presents demographic
information for each cluster.
Cluster 1 (n = 11) was comprised of students who all screened positive for depression and
poor sleep, as well as the majority screening positive for suicidal ideation (73%), PTSD (73%),
illicit drugs (55%), and tobacco (55%). This cluster consisted of all females whose other
demographics were consistent with the full sample.
Cluster 2 (n = 22) was defined by illicit drug use (82%), nonmedical prescription drug
(54.5%), tobacco use (77%), alcohol use (91%), and healthy BMI (0% with unhealthy BMI).
This group had the youngest mean age (21.4 years) and had the greatest proportion of students in
Greek life (46%).
Cluster 3 (n = 31) was defined by at-risk alcohol use (90%) and unhealthy BMI (61%).
This cluster had a greater proportion of White students (58%) relative to the full sample (43%).
Cluster 4 (n = 31) can be described as low-risk, overall, with none of these students
screening positive for at-risk alcohol use, tobacco use, or depression. This cluster consisted of
the oldest students (m = 25.10, SD = 6.81), the greatest proportion of graduate students (68%),
and students who were Asian (48%) or ESL (52%).
Discussion
This sample of 100 students recruited from UHS reported levels of substance use
consistent with national norms (Center for Behavioral Health Statistics and Quality, 2016) and
endorsed multiple behavioral health risk factors. A majority endorsed past-year use of alcohol,
and just over half endorsed past-year concurrent use of multiple substances. The prevalence of
substance use in this sample supports the need for brief screens to detect at-risk substance use
when students present for primary care services.
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Results support the construct validity of the SUBS among students from UHS, extending
its use to university primary care for the first time. Bivariate correlations with the ASSIST
provide evidence of concurrent validity in support of the construct validity of the SUBS as a
brief self-administered screen for at-risk use of alcohol, illicit drug use, nonmedical prescription
drug use, and tobacco use. ROC curves support the utility in the SUBS for detecting at-risk
substance use. This study replicates and extends the validity of the SUBS from its original use
with adults in community-based primary care and hospitals in large cities (Han et al., 2017;
McNeely, Strauss, et al., 2015). Importantly, optimal cut-off scores differ from those suggested
by these initial validation studies.
Optimal cut-off scores on the SUBS vary for different categories of substances.
Consistent with hypotheses, at-risk use of alcohol and illicit drugs, of which cannabis was most
prevalent, were indicated by the higher cut-off of 2. This is consistent with prior research on
single-item screens for substance dependence, which recommends higher cut-offs in order to
maximize specificity (Saitz et al., 2014). Inconsistent with hypotheses, but consistent with
previous research with the SUBS (Han et al., 2017; McNeely, Strauss, et al., 2015), the less
prevalent categories of substances in the current sample (i.e., tobacco, nonmedical prescription
drugs) were best detected by the lower cut-off score of 1. The only nonmedical prescription
drugs endorsed in this sample were sedatives and stimulants. Therefore, results suggest that the
harms of tobacco, prescription sedatives, and prescription stimulants are apparent at lower levels
of use (i.e., one or two days in the past 12 months), whereas harms from alcohol and cannabis
use are more specific to more frequent use (three or more days the past 12 months). This may be
because alcohol and cannabis are the most commonly used substances in this study and in
college settings, in general (Center for Behavioral Health Statistics and Quality, 2016).
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Accordingly, a greater portion of students may be able to use alcohol and cannabis infrequently
without harms (Colby et al., 2009; Fischer et al., 2017).
A secondary aim of this study was to examine the utility of the AUDIT-C and directly
compare the AUDIT-C to the SUBS alcohol item to inform screening practices in primary care.
A lack of statistically significant difference between the AUC for AUDIT-C and SUBS alcohol
item suggests that these screens are comparable in their ability to detect at-risk alcohol use. At a
cut-off score of 2, specificity of the SUBS alcohol item is relatively low (.62). As discussed by
Han and colleagues (2017), such a low specificity may put unnecessary burden on healthcare
providers, as 38% of low-risk individuals would be incorrectly flagged as at-risk (i.e., false
positives) and require allocation of resources for further assessment. The specificity of the
AUDIT-C is somewhat greater, with a specificity of .71 at the cut-off score of 4. In contrast to
the superior specificity for the AUDIT-C, sensitivity is better for the SUBS alcohol item (.85)
relative to the AUDIT-C (.77). Accordingly, within university primary care, providers could
utilize either the SUBS or the AUDIT-C to screen for at-risk alcohol use. If sensitivity is
prioritized and resources are available for follow-up assessment, then the SUBS would be
recommended, with the cut-off score of 2. If specificity is prioritized to minimize false positives,
then the AUDIT-C could be used, due to a lower false positive rate (29%) compared to the SUBS
alcohol item (38%).
The advantages of the AUDIT-C should be considered in light of the additional resources
required for the 3-item screen relative to the advantages of a 4-item screen that also provides
information on other substances. Thus, the practical utility of the SUBS may outweigh the
marginally better diagnostic utility of the AUDIT-C. When considering which screen to
implement in clinical practice, it is important to consider the role of primary care as a potential
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entry point into behavioral health treatment. Accordingly, quantity of information gained should
be considered in addition to minor differences in quality (i.e., differences in AUC values). The
SUBS is clearly superior in terms of breadth of information, given that it screens for tobacco and
drugs in addition to alcohol. However, a disadvantage of the SUBS alcohol item is its lack of
depth compared to the AUDIT-C. The AUDIT-C includes items assessing alcohol use frequency,
quantity, and frequency of heavy drinking; the SUBS alcohol item has only one item and fewer
response options, providing information solely on frequency of heavy drinking. The current
study cannot conclude which screen is best for all university primary care settings, as that
decision should consider the context in which the screen will be used. Contextual factors to
consider include time available for patients to complete screens, time available for scoring (as
the AUDIT-C requires a sum score), and availability of providers to follow up with patients who
screen positive. Another consideration is whether additional screening is taking place, so that
patient burden and disruption to clinical workflows can be minimized (Shepardson &
Funderburk, 2014).
The optimal cut-off score of 4 on the AUDIT-C is unexpectedly low, particularly given
prior research validating the AUDIT-C that recommended a cut-off of 6 for students recruited
from UHS (Campbell, 2015), and specified cut-offs of 5 for females and 7 for males in particular
(Campbell & Maisto, 2018). This difference might be explained by differences in how the at-risk
drinking reference standard is defined. The current study defined at-risk drinking as exceeding
predetermined thresholds on the ASSIST, and the prior study defined at-risk drinking as
exceeding average weekly consumption limits on the Quick Drinking Screen (Sobell et al., 2003)
or endorsing six or more negative drinking consequences on the Brief Young Adult Alcohol
Consequences Questionnaire (Kahler, Strong, & Read, 2005). The lower cut-off score in the
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current study suggests that the ASSIST criterion may be less stringent than criteria used in
previous research.
The lower AUDIT-C cut-off score might also be explained by differences in sample
characteristics, as this sample was older, more racially diverse, and endorsed less heavy drinking
relative to prior research in college students (Campbell & Maisto, 2018; DeMartini & Carey,
2012). The identified cut-off score of 4 is consistent with prior research on the AUDIT-C among
community samples of adults (Bradley et al., 2007; Dawson, Grant, Stinson, & Zhou, 2005),
suggesting the current sample may more closely resemble community samples than, for example,
a sample of introductory psychology students (DeMartini & Carey, 2012). It is also possible that
there was a response bias due to in-person recruitment and data collection used in this study,
whereas prior research with UHS patients recruited via email and was entirely online (Campbell
& Maisto, 2018).
Interestingly, and in contrast with previous research (Kypri, Langley, & Stephenson,
2005; Read, Haas, Radomski, Wickham, & Borish, 2016), a greater proportion of females
screened positive for at-risk alcohol use relative to males. It is unclear why males in this sample
were less likely to be risky drinkers. Further, the AUC for the SUBS alcohol item was not
statistically significant for males alone, perhaps due to the small sample of males in the current
study (n = 23), of whom only 5 met the ASSIST at-risk alcohol use criterion. Accordingly, a cutoff score for males could not be determined. An optimal SUBS alcohol cut-off score of 2 was
identified for all other subgroups, with the exception of ESL students (cut-off score = 1).
Likewise, the AUDIT-C performed differently according to graduate student status, with
a higher AUDIT-C cut-off score identified for undergraduates compared to graduate students.
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The cut-off score of 5 for undergraduates was the same as the cut-off score determined for
females recruited from UHS in previous research (Campbell & Maisto, 2018).
The SUBS also performed differently for graduate students and ESL students. For
graduate students, at-risk illicit drug use was detected at a lower SUBS cut-off score relative to
undergraduate students. This might be explained by differences in substance use motives and
norms, perhaps related to developmental differences between undergraduate and graduate
students. Differences in SUBS cut-off scores for illicit drug use may also reflect differences in
awareness of substance-related problems. Additionally, it may be that graduate students have
been using illicit drugs for longer and therefore may be experiencing more consequences related
to persistent use. Finally, the context of graduate school may be more demanding and therefore
promote more interference from even infrequent use. Given the paucity of research examining
substance use among graduate students, these possibilities warrant further empirical testing.
Lower cut-off scores were also indicated for detecting at-risk alcohol and illicit drug use
among ESL students. This suggests that any past-year use among these students (as indicated by
a SUBS score of 1), and not just repeated use, could be considered potentially problematic and
warrants additional assessment. It could be that some ESL students lack supports and resources
more readily available to native English speakers. Thus, any substance use may be more likely to
be problematic due to a lack of resources to buffer against risk. Alternatively, it could be that
subgroups of students, including ESL students and graduate students, are more aware of and
sensitive to negative consequences and therefore more likely to endorse higher scores on the
ASSIST, which would then translate to meeting the criteria for at-risk use with relatively
infrequent use on the SUBS.
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Further research is needed examining these differences given the small sample sizes for
subgroups and lack of a priori hypotheses, particularly regarding graduate students and ESL
students. Additional differences may exist for nonmedical prescription drug use and tobacco use,
but lack of power may have prevented these differences from being detected in the present
sample.
This study provides information on positive screening rates for other behavioral health
risk factors in addition to substance use. Over half the sample screened positive for sleep
difficulties and at-risk drinking, and over a third screened positive for unhealthy BMI, tobacco
use, and illicit drug use. The prevalence of multiple behavioral health concerns, combined with
the need for efficient screening procedures (Funderburk et al., 2018), supports the use of brief
but comprehensive screening batteries. The SUBS could certainly fit into this type of battery in a
university primary care setting. There is also preliminary evidence for the validity of a relatively
brief but also comprehensive screen, the Primary Care Behavioral Health Screen (Pollard,
Margolis, Niemiec, Salas, & Aatre, 2013), and a 17-item mental health scale in primary care
settings (Behavioral Health Measure-20; Bryan et al., 2014), although these have not been
studied in university primary care. The relative benefits of using a comprehensive behavioral
health questionnaire or a battery comprised of multiple separate screens has yet to be tested
empirically.
An examination of combinations of risk factors suggests that the most common
combinations tended to include at-risk BMI, sleep, and alcohol use. These results support the
need for brief interventions targeting these behavioral health concerns in primary care. Recent
reviews suggest there are evidence-based brief interventions for many of the risk factors
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endorsed in this study, including sleep difficulties, substance use, depression, suicidal ideation,
and weight management (Funderburk & Shepardson, 2015; Funderburk et al., 2018).
Exploratory analyses also indicate that behavioral health risk factors cluster together,
with clusters being primarily defined by depression and other mental health risk factors (Cluster
1), substance use (Cluster 2), at-risk alcohol use and unhealthy BMI (Cluster 3), and a relative
lack of risk factors (Cluster 4). These clusters vary in their demographic makeup, with gender,
graduate student status, Greek life involvement, race, and ESL status varying between groups.
This suggests that screening and subsequent intervention may be especially needed for certain
groups of students (e.g., younger, in Greek life). Consistent with demographic differences in atrisk substance use reported earlier, cluster analyses also suggest lower overall risk among
students who are graduate students, as well as students who are Asian and ESL. Given the
descriptive and exploratory nature of these cluster analyses, they should be considered tentative
and warrant replication in larger samples that more closely resemble the population of students
utilizing UHS.
The four clusters identified in the current study are remarkably similar to clusters
identified in a large multi-site study of community-based primary care patients (n = 1628) that
used latent class analyses and identified four subgroups, described as Mental Health Risk,
Substance Use Risk, Dietary Risk, and Lower Risk (Glenn et al., 2018). Likewise, demographics
of the lower-risk group in the current study are consistent with demographic differences
described by Glenn and colleagues (2018), who reported patients in their Lower Risk group were
more likely to be older and more educated relative to those in the Mental Health Risk group. This
convergence of findings in different populations, using different measures and statistical tests,
provides support for the validity of this clustering of risk factors. Although preliminary, these
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clusters may reflect broader trends in the clustering of behavioral risk factors, and accordingly
may prove a meaningful avenue for further study.
It should be noted that the current study defined at-risk BMI as being either above or
below the healthy BMI range. Of the 40% screening positive for at-risk BMI, the majority were
overweight or obese; specifically, 28% were overweight, 8% obese, and 4% were underweight.
Although being underweight or overweight places students at increased risk for medical and
psychiatric comorbidities, the risk for specific comorbidities varies depending on whether
individuals are above or below the healthy BMI range (Anderson & Good, 2016; Kass et al.,
2017; Odlaug et al, 2015). Accordingly, it would be informative for future research to examine
whether clusters differ when at-risk BMI is examined separately according to under/overweight
status.
Limitations
This study’s results should be considered in light of its limitations. For instance, results
may not generalize to the university as a whole, or to UHS settings at other universities,
particularly given the differences in demographic characteristics between the study sample,
students using UHS, and Syracuse University. Unlike prior research conducted at Syracuse UHS
(Campbell, 2015; Campbell & Maisto, 2018; Funderburk et al., 2012), participant demographics
did not match those of the university as a whole (Syracuse University, 2016). Relative to prior
research that recruited from UHS over email (Campbell, 2015), the current sample has a greater
representation of female, graduate, non-white, and ESL students. Although the reasons for this
are unknown, there may have been features of the recruitment process that inadvertently
appealed to these demographics. Accordingly, this study’s results are limited in their
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generalizability to Syracuse UHS, and also should not be assumed to apply to other UHS settings
without further research.
The order in which study measures were administered may also have affected results.
Participants completed the ASSIST interview first, before moving on to complete the remaining
self-report items on a computer. Completing the ASSIST first may have primed recall of
substance use patterns and thereby increased the accuracy of the SUBS. This is consistent with
how the SUBS was administered in the one other study utilizing the ASSIST and SUBS (Han et
al., 2017). As recommended by Han and colleagues, it would be valuable for future studies to use
counterbalancing to test for any potential order effects to determine whether the SUBS performs
differently when administered before other measures of substance use, particularly since this is
how the SUBS would be used in primary care settings (i.e., given in the waiting room or at the
beginning of the appointment).
An additional limitation relates to the potential impact of social desirability. Previous
research indicates that college students’ concerns with impression management are inversely
related to disclosure of harmful substance use (Davis, Thake, & Vilhena, 2010). Accordingly, the
validity of reported substance use (i.e., on the SUBS, AUDIT-C, and ASSIST) may have been
influenced by social desirability, particularly for reports of illegal substance use and alcohol use
among students who are underage and for whom accurate screening would require them to admit
to illegal activity. Therefore, it is possible that reports of at-risk substance use may be
underestimated due to under-reporting.
In contrast, the location of data collection procedures in a research lab that was nearby,
but separate from, the UHS setting may have encouraged more truthful reports in comparison to
in-person screening, as participants’ reports were confidential and not shared with their medical

38
providers. The study’s data collection procedures may also attenuate the external validity of
these findings, given that screening was completed on a computer rather than on paper. In fact,
research suggests that, relative to paper-based AUDIT-C administration, computer-based
screening is more likely to result in a positive screen and is less affected by social desirability
bias (Graham, Goss, Xu, Magid, & Diguiseppi, 2007). Therefore, this study may overstate the
construct validity of the SUBS and AUDIT-C in primary care due to problems with generalizing
from a confidential research lab to actual screening procedures in primary care settings.
Finally, the sample size was insufficient to cross-validate the cluster analyses. Although it
is promising that results of the cluster analyses resemble those of a large multi-site study in
community-based primary care (Glenn et al., 2018), replication is needed among a larger sample
of university primary care patients.
Future Research Directions
This is the first study to attempt to extend the validity of the SUBS to university primary
care. Accordingly, further research is warranted to replicate these findings. There is also room
for improvement with the SUBS. The low sensitivity of the SUBS alcohol item, in particular,
supports the need for revisions to reduce the potential for false positives. Given the greater
variability and specificity of the AUDIT-C relative to the SUBS, both in the current study and in
previous research (Campbell & Maisto, 2018), the utility of the SUBS might be improved by
combining the AUDIT-C with the SUBS items for tobacco, illicit drugs, and nonmedical
prescription drugs. This would result in a 6-item screen that would help to minimize false
positives for at-risk drinking while also alerting providers to the presence of other at-risk
substance use.

39
Given the importance of provider buy-in for implementing universal screening
(Shepardson & Funderburk, 2014), future research should seek provider feedback regarding the
use and implementation of the SUBS. Provider feedback would also be important to inform how
lengthy the total screening process can be without interfering with necessary workflows (Byhoff
et al., 2019). For example, implementation research suggests that a 28-minute behavioral health
screening tool is not sustainable in community-based primary care (Krist et al., 2014). Within
UHS, in particular, it is unclear at what point screening procedures would be considered too
lengthy by providers, and therefore warrants consideration for future research. Feasibility
research is also warranted to determine whether and how the SUBS could best be integrated into
existing screening practices within university primary care.
Inclusion of a fifth SUBS item screening for concurrent use of multiple substances
represents an important first step toward screening for such use in primary care settings,
particularly given the increased potential for harm when substances are used concurrently
(Agosti et al., 2002; Jacobus, Squeglia, Infante, et al., 2015; Meda et al., 2017). ROC curves
were not generated for the fifth item due to the lack of a reference standard for that criterion.
Further research examining the validity of this item is warranted, and to determine which cut-off
score would detect an increased likelihood of risk related to concurrent use of multiple
substances.
A strength of the current study is that it examined differences in the utility of the SUBS
and AUDIT-C among different subgroups of students, including ESL and graduate students.
Given that lower cut-off scores were indicated for non-native English speakers, future research
could examine differences in English language fluency, and whether oral administration or
translating the SUBS to the individual’s primary language might change how it performs. Future
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research is also needed with a larger sample of males to determine whether and how SUBS cutoff scores might differ for males.
The co-occurrence and clustering of risk factors in this sample suggests a need for brief
interventions targeting multiple risk factors (King et al., 2015; Parekh, Vandelanotte, King, &
Boyle, 2012). The most prevalent combination of risk factors included at-risk alcohol use, sleep,
and BMI. There does not appear to be any research examining brief interventions for this
combination of risk factors. Given the prevalence of these risk factors in the current sample, this
is an important area for future research. Future research could also identify mechanisms common
to these risk factors, thereby informing brief interventions that targeting common mechanisms to
more efficiently effect change across risk factors. For example, mindfulness-based interventions
are theorized to foster self-regulation, as well as increased awareness of moment-to-moment
experience (Vago & Silbersweig, 2012). Research suggests that greater mindfulness is associated
with better psychological and physical health, as well as improved behavioral regulation (Canby,
Cameron, Calhoun, & Buchanan, 2015; Dvořáková et al., 2017; Keng, Smoski, & Robins, 2011;
Roberts & Danoff-Burg, 2011). Accordingly, future research could examine whether students
with multiple risk factors benefit from interventions fostering self-regulation via mindfulness,
such as Acceptance and Commitment Therapy (Hayes, 2004) or Mindfulness-Based Stress
Reduction (Kabat-Zinn, 1990).
The co-occurrence of risk factors also suggests a need to determine whether patients
benefit more from interventions that are provided concurrently or sequentially, and which risk
factors should be addressed first or most intensively. For example, addressing sleep first may
have carry-over effects to improving other behavioral health problems (e.g., Pigeon, Campbell,
Possemato, & Ouimette, 2013). In the current study, sleep disturbances did not differentiate the
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clusters and were endorsed by a majority (65%) of participants. Further, sleep disturbances have
less associated stigma relative to substance use or other behavioral health concerns (Hanschmidt
et al., 2017). Accordingly, further research might test the effects of a brief intervention for sleep
as an initial introduction to behavioral health care, potentially as a more acceptable first step that
could then segue to brief interventions addressing more stigma-laden topics (e.g., depression,
substance use).
Future research could also examine whether the identified clusters of risk factors predict
treatment utilization or other health-related outcomes (Funderburk et al., 2014). Relatedly, UHS
patients present for a variety of appointment types, which may or may not relate to acute illness.
For example, patients can utilize UHS for preventative care, STD testing, psychiatric medication
management, immunizations, or acute illness. Future research could examine whether cluster
membership predicts differences in how patients utilize university primary care. For instance, are
clusters equally represented across appointment types, or are individuals from higher-risk
clusters more likely to utilize certain types of appointments, or at different times? This is an
under-explored area of research that could inform the implementation of screening across
different facets of UHS.
Given the current study’s focus on risk factors, future research might also consider
screening for protective factors (e.g., social support, resilience, spirituality). Screening for
protective factors could facilitate a broader, whole-person perspective and set the tone for
medical appointments incorporating a strengths-based approach rather than being predominantly
problem-focused (Duncan et al., 2007).
Conclusions and Clinical Implications
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This is the first study to provide evidence for the construct validity of a multi-substance
screen in a university primary care setting. Despite limitations in the representativeness of the
sample, results provide preliminary support for the use of the SUBS to screen for at-risk
substance use in this setting, with cut-off scores of 2 for alcohol and illicit drugs, and 1 for
nonmedical prescription drugs and tobacco. Further research is needed examining its validity
among subgroups, including males, ESL students, and graduate students. Examining both the
SUBS and AUDIT-C supports the use of either screen, with the SUBS indicated when resources
are available to follow up on positive screens for substances in addition to alcohol. A strength of
this study is its examination of multiple risk factors in university primary care. Results support
the need for comprehensive screening and combined interventions that maximize the impact on
multiple risk factors.
This study has a number of strengths addressing the limitations of previous research on
screening in university primary care (Campbell, 2015; Campbell & Maisto, 2018). Strengths
include recruiting directly from the UHS waiting room rather than via email, screening for other
drugs and behavioral health concerns in addition to alcohol, and using a more comprehensive
reference standard for at-risk substance use.
Clinical practice would benefit from consistently using validated screens with cut-off
scores determined within the population of interest. Implementation will likely require consistent
educational efforts for primary care providers regarding the use and purpose of screening,
especially if additional screens are perceived as adding to the burden of usual clinical
procedures. Ideally, with adequate educational and implementation efforts, consistent screening
has the potential to improve recognition of at-risk substance use and other behavioral health risk
factors, thereby reducing the individual and public health impact of behavioral health concerns.
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Table 1
Participant Demographic Characteristics
% / m (SD)
Gender
Female
Male
Other
Age
Race
White
Asian
Black
Multi-Racial
Other
Ethnicity
Hispanic
Non-Hispanic
English as first language?
Yes
No
GPA
Year in school
Freshman
Sophomore
Junior
Senior
5th-year Senior
Graduate student
Greek Life
No
Yes

76.8%
23.2%
0.0%
23.32 (5.56)

n
99

100
100

43.0%
34.0%
8.0%
10.0%
5.0%
100
12%
88%
100
67.0%
33.0%
3.43 (0.53)

99
100

15.0%
17.0%
13.0%
11.0%
1.0%
43.0%
100
70.0%
30.0%
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Table 2
Substance Use Screening Information for the Full Sample
Variable
Any past1: 1-2
2: 3+
year use (%) days (%) days (%)
SUBS – Alcohol (4+ drinks)
74
18
56
SUBS – Tobacco (any)
39
15
24
SUBS – Illicit Drugs (any)
56
20
36
SUBS – Rx Drugs (any)
19
11
8
SUBS – Concurrent
51
25
26
AUDIT-C
90
---

Mean

Mdn

SD

1.30
0.63
0.92
0.27
0.77
3.67

2.00
0.00
1.00
0.00
1.00
3.00

0.86
0.85
0.90
0.60
0.84
2.54

Table 3
ASSIST Substance Involvement Scores
ASSIST Variable
Any
Any PastLifetime year use
use (%)
(%)
Alcohol
94
91
Tobacco
54
37
Cannabis
64
54
Prescription Stimulants
18
13
Cocaine
15
13
Hallucinogens
12
4
Prescription Sedatives
11
7
Inhalants
3
0
Prescription Opioids
3
0
Methamphetamine
0
0
Street Sedatives
0
0
Street Opioids
0
0

Mean

Mdn

SD

Min-Max

9.75
3.04
5.16
0.65
0.69
0.21
0.68
0.00
0.00
0.00
0.00
0.00

8.00
0.00
2.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00

7.41
6.08
7.93
2.36
2.28
1.09
3.52
0.00
0.00
0.00
0.00
0.00

0-32
0-31
0-30
0-19
0-14
0-9
0-29
0-0
0-0
0-0
0-0
0-0

MinMax
0-2
0-2
0-2
0-2
0-2
0-10
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Table 4
Nonparametric Correlations Between SUBS Items and ASSIST Sums
Substance
Spearman’s rho
p
Alcohol
.580
< .001
Tobacco
.928
< .001
Illicit Drugs
.878
< .001
Nonmedical Rx Drugs
.769
< .001

Table 5
Nonparametric Correlations Among Alcohol Use Screens
ASSIST Alcohol SUBS Alcohol
ASSIST Alcohol Sum
1.00
--

AUDIT-C
--

SUBS Alcohol Item

.580

1.00

--

AUDIT-C Sum

.677

.736

1.00

Note: All correlations are statistically significant with p < .001.

Table 6
AUC Values for ASSIST At-Risk Criteria
Criterion
AUC SE
SUBS Alcohol
.740
.050
SUBS Tobacco
.885
.038
SUBS Rx Drugs
.795
.104
SUBS Illicit Drugs
.914
.028

p
<.001
<.001
.009
<.001

95% CI
.641 - .838
.811 - .960
.590 - 1.00
.859 - .969

N+
39
22
7
33

N61
78
93
67

Note. N+ indicates positive at-risk status on the ASSIST; N- indicates negative at-risk status on the ASSIST.
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Table 7
Sensitivity, Specificity, & Youden’s Index for SUBS Alcohol and ASSIST At-Risk
Criterion
Cut-off Sensitivity
1-Specificity
Specificity
Youden's Index
1.000
1.000
0
.000
.000
.923
.623
1
.377
.300
.846
.377
2
.623
.469

Table 8
Sensitivity, Specificity, & Youden’s Index for SUBS Illicit Drugs and ASSIST At-Risk
Criterion
Cut-off Sensitivity
1-Specificity
Specificity
Youden's Index
1.000
1.000
0
.000
.000
1.000
.343
1
.657
.657
.848
.119
2
.881
.729

Table 9
Sensitivity, Specificity, & Youden’s Index for SUBS Tobacco and ASSIST At-Risk
Criterion
Cut-off Sensitivity
1-Specificity
Specificity
Youden's Index
1.000
1.000
0
.000
.000
.955
.231
1
.769
.724
.682
.115
2
.885
.566

Table 10
Sensitivity, Specificity, & Youden’s Index for SUBS Nonmedical Prescription Drug
Use and ASSIST At-Risk Criterion
Cut-off Sensitivity
1-Specificity
Specificity
Youden's Index
1.000
1.000
0
.000
.000
.714
.151
1
.849
.564
.429
.054
2
.946
.375
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Table 11
Sensitivity, Specificity, & Youden’s Index for AUDIT-C with ASSIST At-Risk Criterion
Cut-off Sensitivity
1-Specificity
Specificity
Youden's Index
1.000
1.000
0
.000
.000
1.000
.836
1
.164
.164
.974
.574
2
.426
.401
.897
.459
3
.541
.438
.769
.295
4
.705
.474
.667
.213
5
.787
.454
.487
.164
6
.836
.323
.308
.033
7
.967
.275
.179
.016
8
.984
.163
.051
.000
9
1.000
.051
.026
.000
10
1.000
.026

Table 12
Gender Differences in Rates of At-Risk Use on the ASSIST
Males
Females
Variable
% At-Risk
n
% At-Risk
Alcohol
21.7
23
44.7
Tobacco
26.1
23
21.1
Illicit Drugs
26.1
23
35.5
Nonmedical Prescription Drugs
0.0
23
9.2

n
76
76
76
76

Combined
% At-Risk
39.4
22.2
33.3
7.1

c2
3.91
0.26
0.71
2.28

p
.048
.611
.400
.131

c2
3.90
2.85
12.38
2.53

p
.048
.092
.000
.112

Table 13
Graduate Student Status Differences in Rates of At-Risk Use on the ASSIST
Undergraduate
Graduate
Combined
Variable
% At-Risk
n
% At-Risk
n % At-Risk
Alcohol
47.4
57
27.9
43
39.0
Tobacco
28.1
57
14.0
43
22.0
Illicit Drugs
47.4
57
14.0
43
33.0
Nonmedical Prescription Drugs
10.5
57
2.3
43
7.0
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Table 14
English-Language Differences in Rates of At-Risk Use on the ASSIST
English as first
English as
language
second language
Variable
% At-Risk
n
% At-Risk
n
Alcohol
50.7
67
15.2
33
Tobacco
20.9
67
24.2
33
Illicit Drugs
40.3
67
18.2
33
Nonmedical Prescription Drugs
10.4
67
0.0
33

Combined
% At-Risk
39.0
22.0
33.0
7.0

c2
11.78
0.14
4.89
3.71

p
.001
.704
.027
.054

Table 15
Subgroup AUC Curve Analyses Screening for At-Risk Use on the ASSIST
Screen
Subgroup
AUC
SE
p
SUBS Alcohol
Males
0.639 0.129 0.351
Females
0.787 0.054 0.000
Undergraduate
0.719 0.068 0.005
Graduate
0.708 0.091 0.036
st
English 1 language
0.721 0.064 0.002
English 2nd language
0.775 0.086 0.053
AUDIT-C
Males
0.711 0.116 0.157
Females
0.830 0.046 0.000
Undergraduate
0.812 0.056 0.000
Graduate
0.804 0.068 0.002
English 1st language
0.760 0.058 0.000
nd
English 2 language
0.829 0.073 0.021
SUBS Illicit Drugs Undergraduate
0.877 0.048 0.000
Graduate
0.944 0.035 0.001
English 1st language
0.892 0.040 0.000
nd
English 2 language
0.948 0.038 0.001

N+
5
34
27
12
34
5
5
34
27
12
34
5
27
6
27
6

N18
42
30
31
33
28
18
42
30
31
35
28
30
37
40
27

Optimal cut-off
n/a
2
2
2
2
1
n/a
4
5
2
5
2
2
1
2
1
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Table 16
Behavioral Health Screen Information
Variable
Mean
Mdn
SD
Min-Max
n
Depression (PHQ-9)
5.77
5.00
4.51
0-22
94
Suicidal Ideation item
0.15
0.00
0.39
0-2
100
Sleep item
0.94
1.00
0.93
0-3
97
Anxiety (GAD-7)
5.80
5.00
4.38
0-18
100
Posttraumatic Stress (PC-PTSD)
1.11
0.00
1.33
0-4
98
BMI
24.44
23.31
4.59
16.81-44.41
100
Note. Reports were based on past 2 weeks (PHQ-9, suicidal ideation item, sleep item,
GAD-7) and past month (PC-PTSD).

Table 17
Rates of Positive Substance Use Screens and Behavioral Health Screens
Variable
Cut-Off Score Positive Screen
(%)
SUBS – Alcohol (4+ drinks)
2
56.0
SUBS – Tobacco (any)
1
39.0
SUBS – Illicit Drugs (any)
2
36.0
SUBS – Nonmedical Rx Drugs (any)
1
19.0
Depression (PHQ-9)
10
14.1
Suicidal Ideation item
1
14.0
Sleep item
1
64.9
Anxiety (GAD-7)
10
17.0
Posttraumatic Stress (PC-PTSD)
3
17.2
BMI
40.0
< 18.5 or ³ 25

N in analyses
100
100
100
100
99
100
97
100
99
100
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Table 18
Number of Risk Factors
Frequency Percent Cumulative
Percent
0
3
3
3
1
16
16
19
2
23
23
42
3
18
18
60
4
12
12
72
5
12
12
84
6
8
8
92
7
1
1
93
9
2
2
95
Missing
5
5
100

Table 19
Combinations of Risk Factors Endorsed by Multiple Participants
Risk Factor Combination
BMI only
BMI & Sleep
Alcohol & Sleep
Alcohol, BMI, & Sleep
Alcohol, Tobacco, Illicit Drugs, & Sleep
Alcohol only
Alcohol, Tobacco, BMI, & Sleep
Sleep only
None
Alcohol & Tobacco
Alcohol, Tobacco, & BMI
Alcohol, Tobacco, & Illicit Drugs
Alcohol, Tobacco, Illicit Drugs, Sleep, & Anxiety
Alcohol, Tobacco, Illicit Drugs, Rx Drugs, BMI, & Sleep
Alcohol, Tobacco, Illicit Drugs, Rx Drugs, PTSD, & Sleep
Sleep & PTSD

Percent (N = 100)
6.0
5.0
5.0
5.0
4.0
4.0
3.0
3.0
3.0
2.0
2.0
2.0
2.0
2.0
2.0
2.0

51

Table 20
Two Step Cluster Analysis
Cluster 1
2
3
4
Size
11.6% (n = 11)
23.2% (n = 22)
32.6% (n = 31)
32.6% (n = 31)
Variable and positive screen rates within-cluster (sorted by within-cluster importance)
Depression 100%
Illicit Drugs 81.8% Alcohol 90.3%
Alcohol 0%
SI 72.7%
Rx Drugs 54.5%
BMI 61.3%
Tobacco 0%
PTSD 72.7%
Tobacco 77.3%
Anxiety 0%
Illicit Drugs 12.9%
Anxiety 45.5%
BMI 0%
PTSD 0%
Sleep 45.2%
Sleep 100%
Alcohol 90.9%
Illicit Drugs 0% Depression 0%
Illicit Drugs 54.5% SI 0%
Depression 3.2% Rx Drugs 3.2%
Tobacco 54.5%
Anxiety 27.3%
SI 6.5%
BMI 48.4%
BMI 27.3%
Depression 9.1%
Rx Drugs 9.7%
PTSD 12.9%
Rx Drugs 9.1%
Sleep 72.7%
Tobacco 41.9%
SI 12.9%
Alcohol 45.5%
PTSD 13.6%
Sleep 67.7%
Anxiety 16.1%
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Table 21
Cluster Demographic Characteristics
Cluster
1 (n=11)
% Female
100%

2 (n=22)
86.4%

3 (n=31)
61.3%

4 (n=31)
74.2%

Full Sample (N=100)
76.8%

Age (M, SD)

21.36 (2.82)

23.42 (5.75)

25.10 (6.81)

23.32 (5.56)

% Graduate Students 36.4%

27.3%

32.3%

67.7%

43.0%

GPA (M, SD)

3.32 (0.47)

3.47 (0.36)

3.34 (0.74)

3.52 (0.42)

3.43 (0.53)

Race

36.4% Asian
27.3% White
18.2% Black
18.2% Other

40.9% White
31.8% Asian
22.7% Multiracial
4.5% Other

58.1% White
19.4% Asian
12.9% Black
6.4% Multiracial
3.2% Other

48.4% Asian
32.3% White
9.7% Multiracial
6.5% Black
3.2% Other

43.0% White
34.0% Asian
10.0% Multiracial
8.0% Black
5.0% Other

Ethnicity

9.1% Hispanic

27.3% Hispanic

6.5% Hispanic

9.7% Hispanic

12.0%

% in Greek life

18.2%

45.5%

32.3%

19.4%

30.0%

English as 2nd
language

27.3%

22.7%

22.6%

51.6%

33.0%

22.82 (5.36)
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Figure 1. ROC curve for SUBS alcohol item predicting ASSIST at-risk alcohol use. Optimal cutoff score of 2 is indicated by a circle. The diagonal line indicates the theoretical ROC curve for
AUC = .50.
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Figure 2. ROC curve for SUBS tobacco item predicting ASSIST at-risk tobacco use. Optimal
cut-off score of 1 is indicated by a circle. The diagonal line indicates the theoretical ROC curve
for AUC = .50.
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Figure 3. ROC curve for SUBS illicit drug item predicting ASSIST at-risk illicit drug use.
Optimal cut-off score of 2 is indicated by a circle. The diagonal line indicates the theoretical
ROC curve for AUC = .50.
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Figure 4. ROC curve for SUBS nonmedical prescription drug item predicting ASSIST at-risk
nonmedical prescription drug use. Optimal cut-off score of 1 is indicated by a circle. The
diagonal line indicates the theoretical ROC curve for AUC = .50.
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Figure 5. ROC curve for AUDIT-C predicting ASSIST at-risk alcohol use. Optimal cut-off score
of 4 is indicated by a circle. The diagonal line indicates the theoretical ROC curve for AUC =
.50.
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Figure 6. ROC curves for SUBS alcohol item and AUDIT-C predicting ASSIST at-risk alcohol
use.
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Appendix A.
Substance Use Brief Screen (SUBS)

The Substance Use Brief Screen. Reprinted from McNeely, Strauss, et al. (2015), with
permission from Elsevier.
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Appendix B.
Modified 5-Item Substance Use Brief Screen (SUBS)
Instruction: Please check one box Ö for each question

Three or
more days
in the past
12 months

One or
two days
in the past
12 months

Never in
the past
12
months

1. In the past 12 months, on how many days did you use…
Tobacco?
2. In the past 12 months, on how many days did you have…
4 or more alcoholic drinks in a day, including wine or
beer?
Note: Consider a “drink” to be a can or bottle of beer (12 ounces), a glass of wine (5 ounces), a wine
cooler (12 ounces) or a shot of hard liquor like gin, vodka or whiskey (1.5 ounces).
3. In the past 12 months, on how many days did you use…
any Illegal Drug, including marijuana?

4. In the past 12 months, on how many days did you use…
any Prescription Medications “recreationally” (just for
the feeling, or using more than prescribed)?
Note: “Recreationally” means taking medications just for the feeling or experience they cause, to get
high, or taking them more often or at higher doses than prescribed. Prescription Medications are those
that are prescribed to you or to someone else.
5. In the past 12 months, on how many days did you use…
more than one of the above substances on the same
occasion (for example, using marijuana while drinking
alcohol)?
Please indicate which type of substances were used within the same occasion in the past year:
Tobacco
Alcohol
Illegal drug
Prescription medication used recreationally
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Appendix C.
ASSIST Structured Interview
(modified to differentiate nonmedical use of prescription stimulants, sedatives, and opioids)
Introduction (Please read to patient):
Thank you for agreeing to take part in this brief interview about alcohol, tobacco products and
other drugs. I am going to ask you some questions about your experience of using these
substances across your lifetime and in the past twelve months. These substances can be smoked,
swallowed, snorted, inhaled, injected, or taken in the form of pills (show drug card).
Some of the substances listed may be prescribed by a doctor (like amphetamines, sedatives, pain
medications). For this interview, we will not record medications that are used as prescribed by
your doctor. However, if you have taken such medications for reasons other than prescription, or
taken them more frequently or at higher doses than prescribed, please let me know. While we are
also interested in knowing about your use of various illicit drugs, please be assured that
information on such use will be treated as strictly confidential.
Note: before asking questions, give ASSIST response card to patient.
Question 1
In your life, which of the following substances have you ever used? (NONMEDICAL USE ONLY)

No

Yes

a. Tobacco products (cigarettes, chewing tobacco, cigars, etc.)

0

3

b. Alcoholic beverages (beer, wine, spirits, etc.)

0

3

c. Cannabis (marijuana, pot, grass, hash, etc.)

0

3

d. Cocaine (coke, crack, etc.)

0

3

e. Prescription stimulants (Ritalin, Concerta, Dexedrine, Adderall, diet pills, etc.)

0

3

f. Methamphetamine (speed, crystal meth, ice, etc.)

0

3

g. Inhalants (nitrous oxide, glue, gas, paint thinner, etc.)

0

3

h. Prescription sedatives or sleeping pills (Xanax, Valium, Ativan, Klonopin, Librium,
Ambien, Lunesta, etc.)
i. Street sedatives (GHB, Rohypnol, roofies, Seconal, phenobarbital, etc.)

0

3

0

3

j. Hallucinogens (LSD, acid, mushrooms, PCP, Special K, ecstasy, etc.)

0

3

k. Street opioids (heroin, opium, etc.)

0

3

l. Prescription opioids (fentanyl, oxycodone [OxyContin, Percocet], hydrocodone
[Vicodin], methadone, buprenorphine, etc.)
m. Other – specify:

0

3

0

3

If “No” to all items, stop interview.
If “Yes” to any of these items, ask question 2 for each substance ever used.
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Question 2
In the past twelve months, how often have you used the
substances you mentioned (FIRST DRUG, SECOND
DRUG, ETC)?
a. Tobacco products (cigarettes, chewing tobacco, cigars,
etc.)
b. Alcoholic beverages (beer, wine, spirits, etc.)
c. Cannabis (marijuana, pot, grass, hash, etc.)
d. Cocaine (coke, crack, etc.)
e. Prescription stimulants (Ritalin, Concerta, Dexedrine,
Adderall, diet pills, etc.)
f. Methamphetamine (speed, crystal meth, ice, etc.)
g. Inhalants (nitrous oxide, glue, gas, paint thinner, etc.)
h. Prescription sedatives or sleeping pills (Xanax, Valium,
Ativan, Klonopin, Librium, Ambien, Lunesta, etc.)
i. Street sedatives (GHB, Rohypnol, roofies, Seconal,
phenobarbital, etc.)
j. Hallucinogens (LSD, acid, mushrooms, PCP, Special K,
ecstasy, etc.)
k. Street opioids (heroin, opium, etc.)
l. Prescription opioids (fentanyl, oxycodone [OxyContin,
Percocet], hydrocodone [Vicodin], methadone,
buprenorphine, etc.)
m. Other – specify:

Never

Once or
Twice

Monthly

Weekly

0

2

3

4

Daily or
Almost
Daily
6

0
0
0
0

2
2
2
2

3
3
3
3

4
4
4
4

6
6
6
6

0
0
0

2
2
2

3
3
3

4
4
4

6
6
6

0

2

3

4

6

0

2

3

4

6

0
0

2
2

3
3

4
4

6
6

0

2

3

4

6

If “Never” to all items in Question 2, skip to Question 6.
If any substances in Question 2 were used in the previous twelve months, continue with
Questions 3, 4 & 5 for each substance used.
Question 3
During the past twelve months, how often have you had a
strong desire or urge to use (FIRST DRUG, SECOND
DRUG, ETC)?
a. Tobacco products (cigarettes, chewing tobacco, cigars,
etc.)
b. Alcoholic beverages (beer, wine, spirits, etc.)
c. Cannabis (marijuana, pot, grass, hash, etc.)
d. Cocaine (coke, crack, etc.)
e. Prescription stimulants (Ritalin, Concerta, Dexedrine,
Adderall, diet pills, etc.)
f. Methamphetamine (speed, crystal meth, ice, etc.)
g. Inhalants (nitrous oxide, glue, gas, paint thinner, etc.)
h. Prescription sedatives or sleeping pills (Xanax, Valium,
Ativan, Klonopin, Librium, Ambien, Lunesta, etc.)
i. Street sedatives (GHB, Rohypnol, roofies, Seconal,
phenobarbital, etc.)
j. Hallucinogens (LSD, acid, mushrooms, PCP, Special K,
ecstasy, etc.)
k. Street opioids (heroin, opium, etc.)

Never

Once or
Twice

Monthly

Weekly

0

3

4

5

Daily or
Almost
Daily
6

0
0
0
0

3
3
3
3

4
4
4
4

5
5
5
5

6
6
6
6

0
0
0

3
3
3

4
4
4

5
5
5

6
6
6

0

3

4

5

6

0

3

4

5

6

0

3

4

5

6
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l. Prescription opioids (fentanyl, oxycodone [OxyContin,
Percocet], hydrocodone [Vicodin], methadone,
buprenorphine, etc.)
m. Other – specify:

0

3

4

5

6

0

3

4

5

6

Never

Once or
Twice

Monthly

Weekly

0

4

5

6

Daily or
Almost
Daily
7

0
0
0
0

4
4
4
4

5
5
5
5

6
6
6
6

7
7
7
7

0
0
0

4
4
4

5
5
5

6
6
6

7
7
7

0

4

5

6

7

0

4

5

6

7

0
0

4
4

5
5

6
6

7
7

0

4

5

6

7

Never

Once or
Twice

Monthly

Weekly

0

n/a

n/a

n/a

Daily or
Almost
Daily
n/a

0
0
0
0

5
5
5
5

6
6
6
6

7
7
7
7

8
8
8
8

0
0
0

5
5
5

6
6
6

7
7
7

8
8
8

0

5

6

7

8

0

5

6

7

8

0

5

6

7

8

Question 4
During the past twelve months, how often has your use of
(FIRST DRUG, SECOND DRUG, ETC) led to health,
social, legal, or financial problems?
a. Tobacco products (cigarettes, chewing tobacco, cigars,
etc.)
b. Alcoholic beverages (beer, wine, spirits, etc.)
c. Cannabis (marijuana, pot, grass, hash, etc.)
d. Cocaine (coke, crack, etc.)
e. Prescription stimulants (Ritalin, Concerta, Dexedrine,
Adderall, diet pills, etc.)
f. Methamphetamine (speed, crystal meth, ice, etc.)
g. Inhalants (nitrous oxide, glue, gas, paint thinner, etc.)
h. Prescription sedatives or sleeping pills (Xanax, Valium,
Ativan, Klonopin, Librium, Ambien, Lunesta, etc.)
i. Street sedatives (GHB, Rohypnol, roofies, Seconal,
phenobarbital, etc.)
j. Hallucinogens (LSD, acid, mushrooms, PCP, Special K,
ecstasy, etc.)
k. Street opioids (heroin, opium, etc.)
l. Prescription opioids (fentanyl, oxycodone [OxyContin,
Percocet], hydrocodone [Vicodin], methadone,
buprenorphine, etc.)
m. Other – specify:

Question 5
During the past twelve months, how often have you failed
to do what was normally expected of you because of your
use of (FIRST DRUG, SECOND DRUG, ETC)?
a. Tobacco products (cigarettes, chewing tobacco, cigars,
etc.)
b. Alcoholic beverages (beer, wine, spirits, etc.)
c. Cannabis (marijuana, pot, grass, hash, etc.)
d. Cocaine (coke, crack, etc.)
e. Prescription stimulants (Ritalin, Concerta, Dexedrine,
Adderall, diet pills, etc.)
f. Methamphetamine (speed, crystal meth, ice, etc.)
g. Inhalants (nitrous oxide, glue, gas, paint thinner, etc.)
h. Prescription sedatives or sleeping pills (Xanax, Valium,
Ativan, Klonopin, Librium, Ambien, Lunesta, etc.)
i. Street sedatives (GHB, Rohypnol, roofies, Seconal,
phenobarbital, etc.)
j. Hallucinogens (LSD, acid, mushrooms, PCP, Special K,
ecstasy, etc.)
k. Street opioids (heroin, opium, etc.)
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l. Prescription opioids (fentanyl, oxycodone [OxyContin,
Percocet], hydrocodone [Vicodin], methadone,
buprenorphine, etc.)
m. Other – specify:

0

5

6

7

8

0

5

6

7

8

Ask question 6 & 7 for all substances ever used (i.e. those endorsed in Question 1)
Question 6
Has a friend or relative or anyone else ever expressed
concern about your use of (FIRST DRUG, SECOND
DRUG, ETC.)?
a. Tobacco products (cigarettes, chewing tobacco, cigars,
etc.)
b. Alcoholic beverages (beer, wine, spirits, etc.)
c. Cannabis (marijuana, pot, grass, hash, etc.)
d. Cocaine (coke, crack, etc.)
e. Prescription stimulants (Ritalin, Concerta, Dexedrine,
Adderall, diet pills, etc.)
f. Methamphetamine (speed, crystal meth, ice, etc.)
g. Inhalants (nitrous oxide, glue, gas, paint thinner, etc.)
h. Prescription sedatives or sleeping pills (Xanax, Valium,
Ativan, Klonopin, Librium, Ambien, Lunesta, etc.)
i. Street sedatives (GHB, Rohypnol, roofies, Seconal,
phenobarbital, etc.)
j. Hallucinogens (LSD, acid, mushrooms, PCP, Special K,
ecstasy, etc.)
k. Street opioids (heroin, opium, etc.)
l. Prescription opioids (fentanyl, oxycodone [OxyContin,
Percocet], hydrocodone [Vicodin], methadone,
buprenorphine, etc.)
m. Other – specify:

No, Never

Yes, in the past 12
months

Yes, but not in the
past 12 months

0

6

3

0
0
0
0

6
6
6
6

3
3
3
3

0
0
0

6
6
6

3
3
3

0

6

3

0

6

3

0
0

6
6

3
3

0

6

3

No, Never

Yes, in the past 12
months

Yes, but not in the
past 12 months

0

6

3

0
0
0
0

6
6
6
6

3
3
3
3

0
0
0

6
6
6

3
3
3

0

6

3

Question 7
Have you ever tried and failed to control, cut down or
stop using (FIRST DRUG, SECOND DRUG, ETC.)?
a. Tobacco products (cigarettes, chewing tobacco, cigars,
etc.)
b. Alcoholic beverages (beer, wine, spirits, etc.)
c. Cannabis (marijuana, pot, grass, hash, etc.)
d. Cocaine (coke, crack, etc.)
e. Prescription stimulants (Ritalin, Concerta, Dexedrine,
Adderall, diet pills, etc.)
f. Methamphetamine (speed, crystal meth, ice, etc.)
g. Inhalants (nitrous oxide, glue, gas, paint thinner, etc.)
h. Prescription sedatives or sleeping pills (Xanax, Valium,
Ativan, Klonopin, Librium, Ambien, Lunesta, etc.)
i. Street sedatives (GHB, Rohypnol, roofies, Seconal,
phenobarbital, etc.)
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j. Hallucinogens (LSD, acid, mushrooms, PCP, Special K,
ecstasy, etc.)
k. Street opioids (heroin, opium, etc.)
l. Prescription opioids (fentanyl, oxycodone [OxyContin,
Percocet], hydrocodone [Vicodin], methadone,
buprenorphine, etc.)
m. Other – specify:

0

6

3

0
0

6
6

3
3

0

6

3

No, Never

Yes, in the past 12
months

Yes, but not in the
past 12 months

0

2

1

Question 8

Have you ever used any drug by injection?
(non-medical use only)

How to calculate a specific substance involvement score:
For each substance (labelled ‘a’ to ‘l’), add up the scores for questions 2 through 7, inclusive. For
tobacco (substance ‘a’), question 5 is not rated and excluded from the total score.

Ali, R., Awwad, E., Babor, T. F., Bradley, F., Butau, T., Farrell, M., … Vendetti, J. (2002). The
Alcohol, Smoking and Substance Involvement Screening Test (ASSIST): Development,
reliability and feasibility. Addiction, 97(9), 1183–1194. https://doi.org/10.1046/j.13600443.2002.00185.x
Humeniuk, R., & World Health Organization. (2010). The Alcohol, smoking and substance
involvement screening test (ASSIST): Manual for use in primary care. Geneva: World
Health Organization.
National Institute on Drug Abuse. (2009). Resource guide: Screening for drug use in general
medical settings. Retrieved from https://www.drugabuse.gov/publications/resourceguide/preface
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Appendix D.
Alcohol Use Disorders Identification Test – Consumption (AUDIT-C)
Think about your drinking over the past year. Please circle the response that represents the best
answer for you.
Beer or wine coolers:
12 oz.

1 standard drink is equal to:
Wine:
5 oz.

Hard Liquor (shot):
1.5 oz.

1. How often do you have a drink containing alcohol?
0) Never
1) Monthly or less
2) 2-4 times a month
3) 2-3 times a week
4) 4 or more times a week
2. How many drinks containing alcohol do you have on a typical day when you are
drinking?
0) 1 or 2
1) 3 or 4
2) 5 or 6
3) 7 to 9
4) 10 or more
3. How often do you have five or more drinks on one occasion?
0) Never
1) Less than monthly
2) Monthly
3) Weekly
4) Daily or almost daily

Bush, K., Kivlahan, D. R., McDonell, M. B., Fihn, S. D., & Bradley, K. A. (1998). The AUDIT
alcohol consumption questions (AUDIT-C): An effective brief screening test for problem
drinking. Archives of Internal Medicine, 158(16), 1789–1795.
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Appendix E.
PHQ-9
Over the past 2 weeks, how often have you been bothered by any of the following problems:
Not at all

Several
days

More than
half the days

Nearly
every day

1. Little interest or pleasure in
doing things

0

1

2

3

2. Feeling down, depressed, or
hopeless

0

1

2

3

3. Trouble falling or staying asleep,
or sleeping too much

0

1

2

3

4. Feeling tired or having little
energy

0

1

2

3

5. Poor appetite or overeating

0

1

2

3

6. Feeling bad about yourself – or
that you re a failure or have let
yourself or your family down

0

1

2

3

7. Trouble concentrating on things,
such as reading the newspaper or
watching television

0

1

2

3

8. Moving or speaking so slowly
that other people could have
noticed. Or the opposite – being
so fidgety or restless that you
have been moving around a lot
more than usual

0

1

2

3

9. Thought that you would be better
off dead, or of hurting yourself in
some way

0

1

2

3

If you checked off any problems, how difficult have
these problems made it for you to do your work, take
care of things at home, or get along with other
people?

Not difficult at all
Somewhat difficult
Very difficult
Extremely difficult

_____
_____
_____
_____

Kroenke, K., Spitzer, R. L., & Williams, J. B. W. (2001). The PHQ-9: Validity of a brief
depression severity measure. Journal of General Internal Medicine, 16(9), 606–613.
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Appendix F.
Generalized Anxiety Disorder 7-item scale (GAD-7)
Over the last 2 weeks, how often have you
been bothered by the following problems?

Not at all

Several
days

More
than half
the days

Nearly
every day

0

1

2

3

2. Not being able to stop or control
worrying

0

1

2

3

3. Worrying too much about different
things

0

1

2

3

0

1

2

3

0

1

2

3

0

1

2

3

0

1

2

3

1. Feeling nervous, anxious, or on edge

4. Trouble relaxing
5. Being so restless that it is hard to sit still
6. Becoming easily annoyed or irritable
7. Feeling afraid as if something awful
might happen

If you checked off any problems, how difficult have
these made it for you to do your work, take care of
things at home, or get along with other people?

Not difficult at all
Somewhat difficult
Very difficult
Extremely difficult

_____
_____
_____
_____

Spitzer, R. L., Kroenke, K., Williams, J. B. W., & Löwe, B. (2006). A brief measure for
assessing generalized anxiety disorder: The GAD-7. Archives of Internal Medicine,
166(10), 1092–1097. https://doi.org/10.1001/archinte.166.10.1092
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Appendix G.
Primary Care PTSD Screen (PC-PTSD)
In your life, have you ever had any experience that was so frightening, horrible, or upsetting that,
in the past month, you...
1. Have had nightmares about it or thought about it when you did not want to?
YES / NO
2. Tried hard not to think about it or went out of your way to avoid situations that reminded you
of it?
YES / NO
3. Were constantly on guard, watchful, or easily startled?
YES / NO
4. Felt numb or detached from others, activities, or your surroundings?
YES / NO

Prins, A., Ouimette, P., Kimerling, R., Cameron, R. P., Hugelshofer, D. S., Shaw-Hegwer, J.,
Thrailkill, A., Gusman, F.D., Sheikh, J. I. (2003). The primary care PTSD screen (PCPTSD): Development and operating characteristics. Primary Care Psychiatry, 9, 9-14.
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Appendix H.
Demographics Questionnaire
Please provide the following information to help us learn more about you.
1. What is your current age? _______
2. What is your gender?
Male (1)
Female (2)
Other (3)
(If Other) Please specify gender: __________
3. What year are you in your college career? (If you are a graduate student, select last
option.)
1st (1)
2nd (2)
3rd (3)
4th (4)
5th or higher (5)
graduate student (6)
4. What is your current/approximate GPA? _______
5. What racial group(s) best describe(s) you? Select all that apply.
White (1)
Black or African-American (2)
Asian (3)
American Indian or Alaska Native (4)
Native Hawaiian or Other Pacific Islander (5)
Other (6)
(If Other) Please specify race: __________
6. Do you identify as Hispanic, Latino, or Spanish?
Yes (1)
No (0)
7. Is English your first language?
Yes (1)
No (0)
8. Are you a current member of a fraternity or sorority?
_______ Not a member (0)
_______ Yes, new member, not yet initiated (1)
_______ Yes, initiated member (2)
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